JPH0948778A - 2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative - Google Patents

2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative

Info

Publication number
JPH0948778A
JPH0948778A JP7199365A JP19936595A JPH0948778A JP H0948778 A JPH0948778 A JP H0948778A JP 7199365 A JP7199365 A JP 7199365A JP 19936595 A JP19936595 A JP 19936595A JP H0948778 A JPH0948778 A JP H0948778A
Authority
JP
Japan
Prior art keywords
mmol
group
substituted
chloro
pyrrolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7199365A
Other languages
Japanese (ja)
Inventor
Atsuro Terajima
孜郎 寺島
Shogo Nakatani
庄吾 中谷
Kaoru Yamada
薫 山田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Priority to JP7199365A priority Critical patent/JPH0948778A/en
Publication of JPH0948778A publication Critical patent/JPH0948778A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PROBLEM TO BE SOLVED: To obtain the subject new compound having a specific chemical structure, exhibiting strong cytotoxicity and expected to be useful as a carcinostatic agent. SOLUTION: This compound is expressed by formula I R<1> is H, a group of formula: SO2 R<3> [R<3> is a 1-5C (branched)alkyl, a (substituted) aralkyl, a (substituted) aryl], a group of formula: CO2 R<4> (R<4> is R<3> ); R<2> is R<3> ; X is a halogen; A is a group of formula II (n is 0-3), a group of formula III, etc.,}, e.g. 5-(3-chloro-2-pyrrolyl)-2-(cyclohexylhydroxylmethyl)-3-methoxyfuran. The compound of formula I wherein R<1> is H, and A is a group of formula II is obtained by removing an amino-protecting group from a compound of formula IV, and subsequently reacting the reaction product with a compound of formula V without isolating the reaction product.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は強力な細胞毒性を示
し、制癌剤としての用途が期待される新規な2−置換−
3−アルコキシ−5−(ピロール−2−イル)フラン誘
導体に関する。
TECHNICAL FIELD The present invention exhibits a novel cytotoxicity and is expected to be used as an anticancer agent.
It relates to 3-alkoxy-5- (pyrrol-2-yl) furan derivatives.

【0002】[0002]

【従来の技術】優れた制癌剤の開発には社会からの強力
な要請があり、強力な細胞毒性を有する新規な化合物を
創製することは優れた制癌剤の開発において大変重要な
位置を占めている。一般に化合物の制癌活性と制癌スペ
クトルはその化学構造に大きく依存するので、既知のも
のとは異なる新規な構造を有する細胞毒性化合物から、
現在実用に供せられている制癌剤より優れた特徴を有す
る制癌剤が開発される可能性は極めて大きい。
2. Description of the Related Art There is a strong demand from society for the development of excellent anticancer agents, and the creation of new compounds having strong cytotoxicity occupies a very important position in the development of excellent anticancer agents. In general, the antitumor activity and antitumor spectrum of a compound largely depend on its chemical structure, and therefore, from a cytotoxic compound having a novel structure different from the known one,
There is a great possibility that an anticancer drug having characteristics superior to those currently put to practical use will be developed.

【0003】[0003]

【発明が解決しようとする課題】本発明の課題は、新規
な化学構造を有し、しかも強力な細胞毒性を有する新し
い制癌剤を創製するところにある。
The object of the present invention is to create a new anticancer agent having a novel chemical structure and having strong cytotoxicity.

【0004】[0004]

【課題を解決するための手段】本発明者らは鋭意検討し
た結果、新規な化学構造を有し、しかも強力な細胞毒性
を有する化合物として下記一般式[I]および[II]
で表される2−置換−3−アルコキシ−5−(ピロール
−2−イル)フラン誘導体を見出し、本発明を完成させ
た。
Means for Solving the Problems As a result of intensive investigations by the present inventors, the following general formulas [I] and [II] were identified as compounds having a novel chemical structure and having strong cytotoxicity.
The present invention was completed by finding a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by

【0005】すなわち本発明は、下記一般式That is, the present invention has the following general formula

【0006】[0006]

【化10】 Embedded image

【0007】[式中、R1は水素原子またはSO23
しくはCO24で表される基(ただし、R3およびR4
各々、炭素数1〜5の直鎖状もしくは分岐状アルキル
基、置換もしくは無置換のアラルキル基、または置換も
しくは無置換のアリ−ル基を表す)を表し、R2は炭素
数1〜5の直鎖状もしくは分岐状アルキル基、置換もし
くは無置換のアラルキル基、または置換もしくは無置換
のアリ−ル基を表し、Xはハロゲン原子を表す。Aは下
記一般式
[In the formula, R 1 is a hydrogen atom or a group represented by SO 2 R 3 or CO 2 R 4 (provided that R 3 and R 4 are each linear or branched having 1 to 5 carbon atoms) An alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group), R 2 is a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted Represents an aralkyl group or a substituted or unsubstituted aryl group, and X represents a halogen atom. A is the following general formula

【0008】[0008]

【化11】 Embedded image

【0009】(式中、nは0〜3の整数を表す)、また
は下記一般式
(Wherein n represents an integer of 0 to 3) or the following general formula

【0010】[0010]

【化12】 [Chemical 12]

【0011】(式中、nは0〜3の整数を表す)、また
は下記一般式
(Wherein n represents an integer of 0 to 3) or the following general formula

【0012】[0012]

【化13】 Embedded image

【0013】(式中、nは0〜3の整数を表す)、また
は下記一般式
(Wherein n represents an integer of 0 to 3) or the following general formula

【0014】[0014]

【化14】 Embedded image

【0015】(式中、R5は水素原子またはSO26
しくはCO27で表される基(ただし、R6およびR7
各々、炭素数1〜5の直鎖状もしくは分岐状アルキル
基、置換もしくは無置換のアラルキル基、または置換も
しくは無置換のアリ−ル基を表す))、あるいは下記一
般式
(In the formula, R 5 is a hydrogen atom or a group represented by SO 2 R 6 or CO 2 R 7 (provided that R 6 and R 7 are each linear or branched having 1 to 5 carbon atoms). An alkyl group, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group)), or the following general formula

【0016】[0016]

【化15】 Embedded image

【0017】(式中、R5は前記と同様である)を表
す]で表される2−置換−3−アルコキシ−5−(ピロ
ール−2−イル)フラン誘導体、または下記一般式
(Wherein R 5 is as defined above), or a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the formula:

【0018】[0018]

【化16】 Embedded image

【0019】[式中、R2は炭素数1〜5の直鎖状もし
くは分岐状アルキル基、置換もしくは無置換のアラルキ
ル基、または置換もしくは無置換のアリ−ル基を表し、
Xはハロゲン原子を表す。Aは下記
[In the formula, R 2 represents a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group,
X represents a halogen atom. A is below

【0020】[0020]

【化17】 Embedded image

【0021】で表される1−(2H−ピロール−2−イ
リデン)エチル基、または下記
1- (2H-pyrrole-2-ylidene) ethyl group represented by:

【0022】[0022]

【化18】 Embedded image

【0023】で表される5,6−ジヒドロ−4H−イン
ドール−7−イル基]で表される2−置換−3−アルコ
キシ−5−(ピロール−2−イル)フラン誘導体、また
はその薬学的に許容しうる塩を提供する。
2,6-dihydro-4H-indol-7-yl group represented by: 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by: To provide an acceptable salt.

【0024】[0024]

【発明の実施の形態】上記化合物[I]および[II]
の置換基R2、R3、R4、R6、およびR7としてはメチ
ル基、エチル基、プロピル基、イソプロピル基、ブチル
基、sec−ブチル基、tert−ブチル基、ペンチル
基などのアルキル基、フェニルメチル基、フェニルエチ
ル基、ナフチルメチル基などのアラルキル基、フェニル
基、ナフチル基、ピリジル基などのアリール基を表し、
これらのアラルキル基およびアリール基は、ニトロ基、
低級アルキル基、ハロゲン原子、低級アルコキシ基など
で置換されていてもよい。したがって、置換アリール基
としては、p−クロロフェニル基、p−メトキシフェニ
ル基、p−ニトロフェニル基、p−トリル基、2,5−
ジクロロフェニル基、2,4−ジメチルフェニル基、
2,4−ジニトロフェニル基、2−メシチリル基、4−
tert−ブチルフェニル基、2,4,6−トリイソプ
ロピルフェニル基などが例示され、置換アラルキル基と
しては、これら置換アリール基が置換した低級アルキル
基が例示される。なお、低級アルキル基としては、炭素
数1〜5の直鎖状もしくは分岐状アルキル基が例示さ
れ、その具体例として上記のアルキル基を挙げることが
できる。また、Xで表されるハロゲン原子としては、と
くに塩素原子、臭素原子、またはヨウ素原子が挙げられ
る。
BEST MODE FOR CARRYING OUT THE INVENTION The above-mentioned compounds [I] and [II]
The substituents R 2 , R 3 , R 4 , R 6 and R 7 are alkyl such as methyl group, ethyl group, propyl group, isopropyl group, butyl group, sec-butyl group, tert-butyl group and pentyl group. Groups, phenylmethyl groups, phenylethyl groups, aralkyl groups such as naphthylmethyl groups, phenyl groups, naphthyl groups, aryl groups such as pyridyl groups,
These aralkyl groups and aryl groups are nitro groups,
It may be substituted with a lower alkyl group, a halogen atom, a lower alkoxy group or the like. Therefore, as the substituted aryl group, p-chlorophenyl group, p-methoxyphenyl group, p-nitrophenyl group, p-tolyl group, 2,5-
Dichlorophenyl group, 2,4-dimethylphenyl group,
2,4-dinitrophenyl group, 2-mesityryl group, 4-
Examples thereof include a tert-butylphenyl group and 2,4,6-triisopropylphenyl group, and examples of the substituted aralkyl group include lower alkyl groups substituted with these substituted aryl groups. The lower alkyl group is, for example, a linear or branched alkyl group having 1 to 5 carbon atoms, and specific examples thereof include the above alkyl groups. Moreover, as the halogen atom represented by X, a chlorine atom, a bromine atom, or an iodine atom is particularly exemplified.

【0025】上記一般式[I]および[II]で表され
る2−置換−3−アルコキシ−5−(ピロール−2−イ
ル)フラン誘導体は下記の合成工程によって製造するこ
とができる。
The 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivatives represented by the above general formulas [I] and [II] can be produced by the following synthetic steps.

【0026】[0026]

【化19】 Embedded image

【0027】[0027]

【化20】 Embedded image

【0028】[0028]

【化21】 [Chemical 21]

【0029】[0029]

【化22】 Embedded image

【0030】[式中、nは0〜3の整数を表し、R2
3、およびR4は各々、炭素数1〜5の直鎖状もしくは
分岐状アルキル基、置換もしくは無置換のアラルキル
基、または置換もしくは無置換のアリ−ル基を表し、R
5はSO26またはCO27で表される基(ただし、R6
およびR7は各々、炭素数1〜5の直鎖状もしくは分岐
状アルキル基、置換もしくは無置換のアラルキル基、ま
たは置換もしくは無置換のアリ−ル基を表す)を表し、
Xはハロゲン原子を表す]
[In the formula, n represents an integer of 0 to 3, R 2 ,
R 3 and R 4 each represent a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, R 3
5 is a group represented by SO 2 R 6 or CO 2 R 7 (provided that R 6
And R 7 each represents a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group),
X represents a halogen atom]

【0031】第1工程 本工程は、一般式[III]で表される3−アルコキシ
−5−(ピロール−2−イル)フラン誘導体(参考例参
照)のアミノ基の保護基であるスルホニル基を除去し、
生成した一般式[IV]で表される3−アルコキシ−5
−(ピロール−2−イル)フラン誘導体(参考例参照)
を単離することなく一般式[V]で表されるアルデヒド
と反応させ、本発明の化合物である一般式[Ia]で表
される2−置換−3−アルコキシ−5−(ピロール−2
−イル)フラン誘導体を製造するものである。
First Step In this step, a sulfonyl group which is a protecting group for an amino group of a 3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [III] (see Reference Example) is added. Removed,
The resulting 3-alkoxy-5 represented by the general formula [IV]
-(Pyrrol-2-yl) furan derivative (see Reference Example)
Is reacted with an aldehyde represented by the general formula [V] without isolation to give a 2-substituted-3-alkoxy-5- (pyrrole-2 represented by the general formula [Ia] which is a compound of the present invention.
-Yl) to produce a furan derivative.

【0032】スルホニル基の除去は通常適用される条件
[T.W.Greene andP.G.M.Wut
s,”Protective groups in O
rganic Synthesis”,2nd E
d.,Wiley Interscience Pub
lication,John−Wiley & Son
s,New York,1991,pp315−40
5]を用いて行われ、アルデヒドとの反応は同じ条件下
で円滑に進行する。
Removal of the sulfonyl group is the condition usually applied [T. W. Greene and P.P. G. FIG. M. Wut
s, "Protective groups in O
organic Synthesis ”, 2nd E
d. , Wiley Interscience Pub
license, John-Wiley & Son
s, New York, 1991, pp315-40
5] and the reaction with the aldehyde proceeds smoothly under the same conditions.

【0033】第2工程 本工程は、一般式[Ia]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
ピロールのアミノ基をアルキルオキシカルボニル化して
本発明の化合物である一般式[Ib]で表される2−置
換−3−アルコキシ−5−(ピロール−2−イル)フラ
ン誘導体を製造するものである。
Step 2 In this step, the amino group of pyrrole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ia] is alkyloxycarbonylated to form It is intended to produce a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ib] which is a compound of the invention.

【0034】アルキルオキシカルボニル化はクロロギ酸
メチル、クロロギ酸エチル、クロロギ酸ビニル、クロロ
ギ酸プロピル、クロロギ酸イソプロピル、クロロギ酸2
−プロペニル、クロロギ酸ブチル、クロロギ酸イソブチ
ル、クロロギ酸フェニルエチル、クロロギ酸2、2、2
−トリクロロエチル、クロロギ酸2−トリメチルシリル
エチル、クロロギ酸シンナミル、シンナミロキシカルボ
ニロキシベンゾトリアゾイル、クロロギ酸4−ニトロシ
ンナミル、クロロギ酸フェニル、クロロギ酸ベンジル、
クロロギ酸p−メトキシベンジル、クロロギ酸p−ニト
ロベンジル、ジ−tert−ブチルジカルボナ−ト、2
−(tert−ブトキシカルボニロキシイミノ)−2−
フェニルアセトニトリル、9−フルオレニルメチルクロ
リド、1−ベンゾトリアゾイル9−フルオレニルメチル
カルバマ−トなどのアルキルオキシカルボニル化剤を用
いて行われる。
Alkyloxycarbonylation is carried out by methyl chloroformate, ethyl chloroformate, vinyl chloroformate, propyl chloroformate, isopropyl chloroformate, chloroformate 2
-Propenyl, butyl chloroformate, isobutyl chloroformate, phenylethyl chloroformate, 2,2,2 chloroformate
-Trichloroethyl, 2-trimethylsilylethyl chloroformate, cinnamyl chloroformate, cinnamyloxycarbonyloxybenzotriazoyl, 4-nitrocinnamyl chloroformate, phenyl chloroformate, benzyl chloroformate,
P-Methoxybenzyl chloroformate, p-nitrobenzyl chloroformate, di-tert-butyl dicarbonate, 2
-(Tert-Butoxycarbonyloxyimino) -2-
It is carried out using an alkyloxycarbonylating agent such as phenylacetonitrile, 9-fluorenylmethyl chloride, 1-benzotriazoyl 9-fluorenylmethylcarbamate.

【0035】反応は塩基を共存させて行う場合もある。
共存させる塩基としてはトリエチルアミン、エチルジイ
ソプロピルアミン、ピリジン、ピペリジン、ピロリジ
ン、イミダゾ−ル、4−(ジメチルアミノ)ピリジン、
N,N−ジエチルアニリン、1,5−ジアザビシクロ
[4.3.0]ノナ−5−エン、1,4−ジアザビシク
ロ[2.2.2]オクタン、1,8−ジアザビシクロ
[5.4.0]ウンデカ−7−エン、炭酸カリウム、炭
酸ナトリウム、炭酸水素ナトリウム、水酸化カリウム、
水酸化ナトリウムなどが用いられる。
The reaction may be carried out in the presence of a base.
Examples of the coexisting base include triethylamine, ethyldiisopropylamine, pyridine, piperidine, pyrrolidine, imidazole, 4- (dimethylamino) pyridine,
N, N-diethylaniline, 1,5-diazabicyclo [4.3.0] non-5-ene, 1,4-diazabicyclo [2.2.2] octane, 1,8-diazabicyclo [5.4.0] ] Undec-7-ene, potassium carbonate, sodium carbonate, sodium hydrogen carbonate, potassium hydroxide,
Sodium hydroxide or the like is used.

【0036】反応は通常溶媒中で行われ、溶媒としては
反応に関与しないものであればいかなるものでも用いる
ことができるが、ペンタン、ヘキサン、シクロヘキサ
ン、ベンゼン、トルエン、キシレンなどの炭化水素系溶
媒、ジクロロメタン、1,2−ジクロロエタン、クロロ
ホルム、四塩化炭素などのハロゲン化炭化水素系溶媒、
ジエチルエ−テル、ジイソプロピルエ−テル、テトラヒ
ドロフラン、1,4−ジオキサンなどのエ−テル系溶
媒、メタノ−ル、エタノ−ル、1−プロパノ−ル、2−
プロパノ−ル、1−ブタノ−ル、2−ブタノ−ル、2−
メチル−1−プロパノ−ル、2−メチル−2−プロパノ
−ルなどのアルコール系溶媒、アセトニトリル、プロピ
オニトリル、アセトン、ニトロメタン、ニトロエタン、
N,N−ジメチルホルムアミド、ジメチルスルホキシド
などの非プロトン性極性溶媒が用いられる。塩基が液体
の場合には塩基を溶媒に兼用して用いることもできる。
反応は−50℃から50℃で円滑に進行する。
The reaction is usually carried out in a solvent, and any solvent which does not participate in the reaction can be used, but hydrocarbon solvents such as pentane, hexane, cyclohexane, benzene, toluene and xylene, Halogenated hydrocarbon solvents such as dichloromethane, 1,2-dichloroethane, chloroform and carbon tetrachloride,
Ether-type solvents such as diethyl ether, diisopropyl ether, tetrahydrofuran, 1,4-dioxane, methanol, ethanol, 1-propanol, 2-
Propanol, 1-butanol, 2-butanol, 2-
Methyl-1-propanol, alcohol solvents such as 2-methyl-2-propanol, acetonitrile, propionitrile, acetone, nitromethane, nitroethane,
An aprotic polar solvent such as N, N-dimethylformamide or dimethylsulfoxide is used. When the base is a liquid, the base can also be used as a solvent.
The reaction proceeds smoothly at -50 ° C to 50 ° C.

【0037】第3工程 本工程は、一般式[Ib]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
水酸基をスルホニル化すると同時に生成するスルホナー
トを脱離させ、本発明の化合物である一般式[Ic]で
表される2−置換−3−アルコキシ−5−(ピロール−
2−イル)フラン誘導体を製造するものである。
Third Step In this step, the hydroxyl group of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ib] is sulfonylated and, at the same time, the sulfonate formed is removed. 2-substituted-3-alkoxy-5- (pyrrole-, represented by the general formula [Ic], which is a compound of the present invention.
2-yl) furan derivative is produced.

【0038】スルホニル化はメタンスルホニルクロリ
ド、エタンスルホニルクロリド、1−プロパンスルホニ
ルクロリド、イソプロピルスルホニルクロリド、1−ブ
タンスルホニルクロリド、ベンゼンスルホニルクロリ
ド、p−クロロベンゼンスルホニルクロリド、p−メト
キシベンゼンスルホニルクロリド、p−ニトロベンゼン
スルホニルクロリド、α−トルエンスルホニルクロリ
ド、p−トルエンスルホニルクロリド、2,5−ジクロ
ロベンゼンスルホニルクロリド、2,4−ジメチルベン
ゼンスルホニルクロリド、2,4−ジニトロベンゼンス
ルホニルクロリド、2−ニトロ−α−トルエンスルホニ
ルクロリド、2−メシチレンスルホニルクロリド、4−
tert−ブチルベンゼンスルホニルクロリド、2,
4,6−トリイソプロピルベンゼンスルホニルクロリ
ド、メタンスルホン酸無水物、p−トルエンスルホン酸
無水物などのスルホニル化剤を用いておこなわれる。
Sulfonylation is carried out by methanesulfonyl chloride, ethanesulfonyl chloride, 1-propanesulfonyl chloride, isopropylsulfonyl chloride, 1-butanesulfonyl chloride, benzenesulfonyl chloride, p-chlorobenzenesulfonyl chloride, p-methoxybenzenesulfonyl chloride, p-nitrobenzene. Sulfonyl chloride, α-toluenesulfonyl chloride, p-toluenesulfonyl chloride, 2,5-dichlorobenzenesulfonyl chloride, 2,4-dimethylbenzenesulfonyl chloride, 2,4-dinitrobenzenesulfonyl chloride, 2-nitro-α-toluenesulfonyl Chloride, 2-mesitylene sulfonyl chloride, 4-
tert-butylbenzenesulfonyl chloride, 2,
It is carried out using a sulfonylating agent such as 4,6-triisopropylbenzenesulfonyl chloride, methanesulfonic anhydride, p-toluenesulfonic anhydride.

【0039】反応は塩基の存在下で行われ、塩基として
はトリエチルアミン、エチルジイソプロピルアミン、ピ
リジン、4−(ジメチルアミノ)ピリジン、N,N−ジ
エチルアニリン、1,5−ジアザビシクロ[4.3.
0]ノナ−5−エン、1,4−ジアザビシクロ[2.
2.2]オクタン、1,8−ジアザビシクロ[5.4.
0]ウンデカ−7−エンなどが用いられる。
The reaction is carried out in the presence of a base, and as the base, triethylamine, ethyldiisopropylamine, pyridine, 4- (dimethylamino) pyridine, N, N-diethylaniline, 1,5-diazabicyclo [4.3.
0] non-5-ene, 1,4-diazabicyclo [2.
2.2] Octane, 1,8-diazabicyclo [5.4.
0] Undeca-7-ene or the like is used.

【0040】反応は通常溶媒中で行われ、溶媒としては
反応に関与しないものであればいかなるものでも用いる
ことができるが、ペンタン、ヘキサン、シクロヘキサ
ン、ベンゼン、トルエン、キシレンなどの炭化水素系溶
媒、ジクロロメタン、1,2−ジクロロエタン、クロロ
ホルム、四塩化炭素などのハロゲン化炭化水素系溶媒、
ジエチルエ−テル、ジイソプロピルエ−テル、テトラヒ
ドロフラン、1,4−ジオキサンなどのエ−テル系溶
媒、またはアセトニトリルが好適に用いられる。また塩
基としてピリジンを用いる場合には、ピリジンを溶媒に
兼用して用いることもできる。反応は−20℃から50
℃で円滑に進行する。
The reaction is usually carried out in a solvent, and any solvent that does not participate in the reaction can be used, but hydrocarbon solvents such as pentane, hexane, cyclohexane, benzene, toluene and xylene, Halogenated hydrocarbon solvents such as dichloromethane, 1,2-dichloroethane, chloroform and carbon tetrachloride,
An ether solvent such as diethyl ether, diisopropyl ether, tetrahydrofuran, 1,4-dioxane, or acetonitrile is preferably used. When pyridine is used as the base, pyridine can also be used as a solvent. The reaction is from -20 ° C to 50
Proceed smoothly at ℃.

【0041】第4工程 本工程は、一般式[Ic]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体ピ
ロールのアミノ基の保護基であるアルキルオキシカルボ
ニル基を除去し、本発明の化合物である一般式[Id]
で表される2−置換−3−アルコキシ−5−(ピロール
−2−イル)フラン誘導体を製造するものである。
Fourth Step In this step, a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ic] is alkyloxycarbonyl which is a protecting group for the amino group of pyrrole. The group is removed to give a compound of the invention of the general formula [Id]
A 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by

【0042】保護基の除去は用いられている保護基に通
常適用される条件[T.W.Greene and
P.G.M.Wuts,”Protective gr
oups in Organic Synthesi
s”,2nd Ed.,Wiley Intersci
ence Publication,John−Wil
ey & Sons,New York,1991,p
p315−405]を用いて行われる。
Removal of the protecting group is subject to conditions normally applied to the protecting group used [T. W. Greene and
P. G. FIG. M. Wuts, "Protective gr
oops in Organic Synthesi
s ", 2nd Ed., Wiley Intersci
ence Publication, John-Wil
ey & Sons, New York, 1991, p
p315-405].

【0043】第5工程 本工程は、一般式[III]で表される3−アルコキシ
−5−(ピロール−2−イル)フラン誘導体のアミノ基
の保護基であるスルホニル基を除去し、生成した一般式
[IV]で表される3−アルコキシ−5−(ピロール−
2−イル)フラン誘導体を単離することなく一般式[V
II]で表されるケトンと縮合させ、本発明の化合物で
ある一般式[Ie]で表される2−置換−3−アルコキ
シ−5−(ピロール−2−イル)フラン誘導体を製造す
るものである。
Fifth Step This step was produced by removing the sulfonyl group, which is a protecting group for the amino group of the 3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [III]. 3-alkoxy-5- (pyrrole-represented by the general formula [IV]
The 2-yl) furan derivative can be isolated by the general formula [V
II] is condensed with a ketone represented by the formula [II] to produce a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ie] of the present invention. is there.

【0044】スルホニル基の除去は通常適用される条件
[T.W.Greene andP.G.M.Wut
s,”Protective groups in O
rganic Synthesis”,2nd E
d.,Wiley Interscience Pub
lication,John−Wiley & Son
s,New York,1991,pp315−40
5]を用いて行われ、ケトンとの反応は同じ条件下で円
滑に進行する。
Removal of the sulfonyl group is the condition usually applied [T. W. Greene and P.P. G. FIG. M. Wut
s, "Protective groups in O
organic Synthesis ”, 2nd E
d. , Wiley Interscience Pub
license, John-Wiley & Son
s, New York, 1991, pp315-40
5] and the reaction with the ketone proceeds smoothly under the same conditions.

【0045】第6工程 本工程は、一般式[III]で表される3−アルコキシ
−5−(ピロール−2−イル)フラン誘導体と一般式
[VIII]で表される2−アセチルピロール誘導体を
オルトギ酸トリメチルと酸の存在下に縮合させ、本発明
の化合物である一般式[If]で表される2−置換−3
−アルコキシ−5−(ピロール−2−イル)フラン誘導
体を製造するものである。
Sixth Step In this step, a 3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [III] and a 2-acetylpyrrole derivative represented by the general formula [VIII] are prepared. The 2-substituted-3 represented by the general formula [If], which is a compound of the present invention, is condensed with trimethyl orthoformate in the presence of an acid.
-Alkoxy-5- (pyrrol-2-yl) furan derivative.

【0046】用いられる酸としてはフッ化水素、塩化水
素、臭化水素、ヨウ化水素、塩素酸、臭素酸、過塩素
酸、過ヨウ素酸、硝酸、硫酸、リン酸、ホウ酸、三フッ
化ホウ素などの無機酸、または、酢酸、トリフルオロ酢
酸、蟻酸、安息香酸、クエン酸、酒石酸、リンゴ酸、カ
ンファスルホン酸、メタンスルホン酸、トリフルオロメ
タンスルホン酸、ベンゼンスルホン酸、p−トルエンス
ルホン酸、ピリジニウムp−トルエンスルホナ−トなど
の有機酸が用いられ、好適にはカンファスルホン酸が用
いられる。
Acids used include hydrogen fluoride, hydrogen chloride, hydrogen bromide, hydrogen iodide, chloric acid, bromic acid, perchloric acid, periodic acid, nitric acid, sulfuric acid, phosphoric acid, boric acid, trifluoride. Inorganic acids such as boron, or acetic acid, trifluoroacetic acid, formic acid, benzoic acid, citric acid, tartaric acid, malic acid, camphorsulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, An organic acid such as pyridinium p-toluenesulfonate is used, and camphorsulfonic acid is preferably used.

【0047】反応は通常溶媒中で行われ、溶媒としては
反応に関与しないものであればいかなるものでも用いる
ことができるが、ペンタン、ヘキサン、シクロヘキサ
ン、ベンゼン、トルエン、キシレンなどの炭化水素系溶
媒、ジクロロメタン、1,2−ジクロロエタン、クロロ
ホルム、四塩化炭素などのハロゲン化炭化水素系溶媒、
ジエチルエ−テル、ジイソプロピルエ−テル、テトラヒ
ドロフラン、1,4−ジオキサンなどのエ−テル系溶
媒、メタノ−ル、エタノ−ル、1−プロパノ−ル、2−
プロパノ−ル、1−ブタノ−ル、2−ブタノ−ル、2−
メチル−1−プロパノ−ル、2−メチル−2−プロパノ
−ルなどのアルコール系溶媒、アセトニトリル、プロピ
オニトリル、アセトン、ニトロメタン、ニトロエタン、
N,N−ジメチルホルムアミド、ジメチルスルホキシド
などの非プロトン性極性溶媒が用いられ、好適にはメタ
ノールが用いられる。また、オルトギ酸トリメチルを溶
媒に兼用して用いることもできる。反応は−50℃から
50℃で円滑に進行する。
The reaction is usually carried out in a solvent, and any solvent which does not participate in the reaction can be used, but hydrocarbon solvents such as pentane, hexane, cyclohexane, benzene, toluene and xylene, Halogenated hydrocarbon solvents such as dichloromethane, 1,2-dichloroethane, chloroform and carbon tetrachloride,
Ether-type solvents such as diethyl ether, diisopropyl ether, tetrahydrofuran, 1,4-dioxane, methanol, ethanol, 1-propanol, 2-
Propanol, 1-butanol, 2-butanol, 2-
Methyl-1-propanol, alcohol solvents such as 2-methyl-2-propanol, acetonitrile, propionitrile, acetone, nitromethane, nitroethane,
An aprotic polar solvent such as N, N-dimethylformamide or dimethylsulfoxide is used, and preferably methanol is used. In addition, trimethyl orthoformate can also be used as a solvent. The reaction proceeds smoothly at -50 ° C to 50 ° C.

【0048】第7工程 本工程は、一般式[If]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
一方のピロールのアミノ基の保護基を除去し、本発明の
化合物である一般式[Ig]で表される2−置換−3−
アルコキシ−5−(ピロール−2−イル)フラン誘導体
を製造するものである。
Seventh Step In this step, the protecting group for the amino group of one pyrrole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [If] is removed. 2-substituted-3-, represented by the general formula [Ig], which is a compound of the present invention.
It is intended to produce an alkoxy-5- (pyrrol-2-yl) furan derivative.

【0049】保護基の除去は用いられてる保護基に通常
適用される条件[T.W.Greene and P.
G.M.Wuts,”Protective grou
psin Organic Synthesis”,2
nd Ed.,WileyInterscience
Publication,John−Wiley& S
ons,New York,1991,pp315−4
05]を用いて行われる。
Removal of the protecting group is subject to conditions normally applied to the protecting group used [T. W. Greene and P.M.
G. FIG. M. Wuts, "Protective group
psin Organic Synthesis ”, 2
nd Ed. , WileyInterscience
Publication, John-Wiley & S
ons, New York, 1991, pp315-4
05].

【0050】第8工程 本工程は、一般式[If]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
一方のピロールのアミノ基の保護基であるスルホニル基
を除去し、本発明の化合物である一般式[Ih]で表さ
れる2−置換−3−アルコキシ−5−(ピロール−2−
イル)フラン誘導体を製造するものである。
Eighth Step This step is a protecting group for the amino group of one pyrrole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [If]. The sulfonyl group is removed, and 2-substituted-3-alkoxy-5- (pyrrole-2-one represented by the general formula [Ih], which is a compound of the present invention, is removed.
Il) to produce a furan derivative.

【0051】スルホニル基の除去は通常適用される条件
[T.W.Greene andP.G.M.Wut
s,”Protective groups in O
rganic Synthesis”,2nd E
d.,Wiley Interscience Pub
lication,John−Wiley & Son
s,New York,1991,pp315−40
5]を用いて行われる。
Removal of the sulfonyl group is the condition usually applied [T. W. Greene and P.P. G. FIG. M. Wut
s, "Protective groups in O
organic Synthesis ”, 2nd E
d. , Wiley Interscience Pub
license, John-Wiley & Son
s, New York, 1991, pp315-40
5].

【0052】第9工程 本工程は、一般式[Ih]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
ピロールの保護基を除去し、本発明の化合物である一般
式[IIa]で表される2−置換−3−アルコキシ−5
−(ピロール−2−イル)フラン誘導体、またはその塩
を製造するものである。
Ninth Step In this step, the protecting group of pyrrole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ih] is removed to obtain the compound of the present invention. 2-Substituted-3-alkoxy-5 represented by the general formula [IIa], which is a compound
A-(pyrrol-2-yl) furan derivative or a salt thereof is produced.

【0053】保護基の除去は用いられてる保護基に通常
適用される条件[T.W.Greene and P.
G.M.Wuts,”Protective grou
psin Organic Synthesis”,2
nd Ed.,WileyInterscience
Publication,John−Wiley& S
ons,New York,1991,pp315−4
05]を用いて行われる。
Removal of the protecting group is a condition commonly applied to the protecting group used [T. W. Greene and P.M.
G. FIG. M. Wuts, "Protective group
psin Organic Synthesis ”, 2
nd Ed. , WileyInterscience
Publication, John-Wiley & S
ons, New York, 1991, pp315-4
05].

【0054】第10工程 本工程は、一般式[III]で表される3−アルコキシ
−5−(ピロール−2−イル)フラン誘導体と一般式
[IX]で表されるテトラヒドロインドール誘導体をオ
ルトギ酸トリメチルと酸の存在下に縮合させ、本発明の
化合物である一般式[Ii]で表される2−置換−3−
アルコキシ−5−(ピロール−2−イル)フラン誘導体
を製造するものである。
Step 10 In this step, the 3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [III] and the tetrahydroindole derivative represented by the general formula [IX] are treated with orthoformic acid. 2-Substitution-3-3 represented by the general formula [Ii], which is a compound of the present invention, by condensation with trimethyl in the presence of an acid.
It is intended to produce an alkoxy-5- (pyrrol-2-yl) furan derivative.

【0055】用いられる酸としてはフッ化水素、塩化水
素、臭化水素、ヨウ化水素、塩素酸、臭素酸、過塩素
酸、過ヨウ素酸、硝酸、硫酸、リン酸、ホウ酸、三フッ
化ホウ素などの無機酸、または、酢酸、トリフルオロ酢
酸、蟻酸、安息香酸、クエン酸、酒石酸、リンゴ酸、カ
ンファスルホン酸、メタンスルホン酸、トリフルオロメ
タンスルホン酸、ベンゼンスルホン酸、p−トルエンス
ルホン酸、ピリジニウムp−トルエンスルホナ−トなど
の有機酸が用いられ、好適にはカンファスルホン酸が用
いられる。
Acids used include hydrogen fluoride, hydrogen chloride, hydrogen bromide, hydrogen iodide, chloric acid, bromic acid, perchloric acid, periodic acid, nitric acid, sulfuric acid, phosphoric acid, boric acid, trifluoride. Inorganic acids such as boron, or acetic acid, trifluoroacetic acid, formic acid, benzoic acid, citric acid, tartaric acid, malic acid, camphorsulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, An organic acid such as pyridinium p-toluenesulfonate is used, and camphorsulfonic acid is preferably used.

【0056】反応は通常溶媒中で行われ、溶媒としては
反応に関与しないものであればいかなるものでも用いる
ことができるが、ペンタン、ヘキサン、シクロヘキサ
ン、ベンゼン、トルエン、キシレンなどの炭化水素系溶
媒、ジクロロメタン、1,2−ジクロロエタン、クロロ
ホルム、四塩化炭素などのハロゲン化炭化水素系溶媒、
ジエチルエ−テル、ジイソプロピルエ−テル、テトラヒ
ドロフラン、1,4−ジオキサンなどのエ−テル系溶
媒、メタノ−ル、エタノ−ル、1−プロパノ−ル、2−
プロパノ−ル、1−ブタノ−ル、2−ブタノ−ル、2−
メチル−1−プロパノ−ル、2−メチル−2−プロパノ
−ルなどのアルコール系溶媒、アセトニトリル、プロピ
オニトリル、アセトン、ニトロメタン、ニトロエタン、
N,N−ジメチルホルムアミド、ジメチルスルホキシド
などの非プロトン性極性溶媒が用いられ、好適にはメタ
ノールが用いられる。また、オルトギ酸トリメチルを溶
媒に兼用して用いることもできる。反応は−50℃から
50℃で円滑に進行する。
The reaction is usually carried out in a solvent, and any solvent which does not participate in the reaction can be used, but hydrocarbon solvents such as pentane, hexane, cyclohexane, benzene, toluene and xylene, Halogenated hydrocarbon solvents such as dichloromethane, 1,2-dichloroethane, chloroform and carbon tetrachloride,
Ether-type solvents such as diethyl ether, diisopropyl ether, tetrahydrofuran, 1,4-dioxane, methanol, ethanol, 1-propanol, 2-
Propanol, 1-butanol, 2-butanol, 2-
Methyl-1-propanol, alcohol solvents such as 2-methyl-2-propanol, acetonitrile, propionitrile, acetone, nitromethane, nitroethane,
An aprotic polar solvent such as N, N-dimethylformamide or dimethylsulfoxide is used, and preferably methanol is used. In addition, trimethyl orthoformate can also be used as a solvent. The reaction proceeds smoothly at -50 ° C to 50 ° C.

【0057】第11工程 本工程は、一般式[Ii]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
ジヒドロインドールのアミノ基の保護基を除去し、本発
明の化合物である一般式[Ij]で表される2−置換−
3−アルコキシ−5−(ピロール−2−イル)フラン誘
導体を製造するものである。
Eleventh step In this step, the protecting group for the amino group of dihydroindole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ii] is removed. A 2-substituted- represented by the general formula [Ij], which is a compound of the present invention:
A 3-alkoxy-5- (pyrrol-2-yl) furan derivative is produced.

【0058】保護基の除去は用いられてる保護基に通常
適用される条件[T.W.Greene and P.
G.M.Wuts,”Protective grou
psin Organic Synthesis”,2
nd Ed.,WileyInterscience
Publication,John−Wiley& S
ons,New York,1991,pp315−4
05]を用いて行われる。
Removal of the protecting group is subject to conditions normally applied to the protecting group used [T. W. Greene and P.M.
G. FIG. M. Wuts, "Protective group
psin Organic Synthesis ”, 2
nd Ed. , WileyInterscience
Publication, John-Wiley & S
ons, New York, 1991, pp315-4
05].

【0059】第12工程 本工程は、一般式[Ii]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
ピロールのアミノ基の保護基であるスルホニル基を除去
し、本発明の化合物である一般式[Ik]で表される2
−置換−3−アルコキシ−5−(ピロール−2−イル)
フラン誘導体を製造するものである。
Twelfth Step This step is a sulfonyl group which is a protecting group for the amino group of the pyrrole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ii]. And is represented by the formula [Ik] which is a compound of the present invention.
-Substituted-3-alkoxy-5- (pyrrol-2-yl)
A furan derivative is produced.

【0060】スルホニル基の除去は通常適用される条件
[T.W.Greene andP.G.M.Wut
s,”Protective groups in O
rganic Synthesis”,2nd E
d.,Wiley Interscience Pub
lication,John−Wiley & Son
s,New York,1991,pp315−40
5]を用いて行われる。
Removal of the sulfonyl group is the condition usually applied [T. W. Greene and P.P. G. FIG. M. Wut
s, "Protective groups in O
organic Synthesis ”, 2nd E
d. , Wiley Interscience Pub
license, John-Wiley & Son
s, New York, 1991, pp315-40
5].

【0061】第13工程 本工程は、一般式[Ik]で表される2−置換−3−ア
ルコキシ−5−(ピロール−2−イル)フラン誘導体の
ジヒドロインドールのアミノ基の保護基を除去し、本発
明の化合物である一般式[IIb]で表される2−置換
−3−アルコキシ−5−(ピロール−2−イル)フラン
誘導体、またはその塩を製造するものである。
Thirteenth Step In this step, the protecting group for the amino group of dihydroindole of the 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ik] is removed. , A 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [IIb], which is a compound of the present invention, or a salt thereof.

【0062】保護基の除去は用いられてる保護基に通常
適用される条件[T.W.Greene and P.
G.M.Wuts,”Protective grou
psin Organic Synthesis”,2
nd Ed.,WileyInterscience
Publication,John−Wiley& S
ons,New York,1991,pp315−4
05]を用いて行われる。
Removal of the protecting group is subject to conditions normally applied to the protecting group used [T. W. Greene and P.M.
G. FIG. M. Wuts, "Protective group
psin Organic Synthesis ”, 2
nd Ed. , WileyInterscience
Publication, John-Wiley & S
ons, New York, 1991, pp315-4
05].

【0063】本発明化合物を制癌剤として使用する際
に、本発明の化合物は薬学的に許容しうる塩としても使
用される。薬学的に許容しうる塩の典型例としては、例
えば炭酸、燐酸、塩酸、硫酸等の無機酸との塩、酢酸、
プロピオン酸、フマル酸、クエン酸、トリフルオロ酢
酸、パラトルエンスルホン酸、トリフルオロメタンスル
ホン酸等の有機酸との塩を挙げることができる。
When the compound of the present invention is used as an anticancer agent, the compound of the present invention is also used as a pharmaceutically acceptable salt. Typical examples of pharmaceutically acceptable salts include salts with inorganic acids such as carbonic acid, phosphoric acid, hydrochloric acid, sulfuric acid, acetic acid,
Examples thereof include salts with organic acids such as propionic acid, fumaric acid, citric acid, trifluoroacetic acid, paratoluenesulfonic acid and trifluoromethanesulfonic acid.

【0064】以上のごとくして得られた上記一般式
[I]および[II]で表される2−置換−3−アルコ
キシ−5−(ピロール−2−イル)フラン誘導体につい
て悪性腫瘍細胞増殖阻害活性試験を行い、これらの化合
物が強力な細胞毒性を示し、制癌剤としての用途を有す
ることを確認した。
The 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivatives represented by the above general formulas [I] and [II], obtained as described above, inhibit the growth of malignant tumor cells. An activity test was carried out and it was confirmed that these compounds showed strong cytotoxicity and had use as anticancer agents.

【0065】以下、参考例、実施例、試験例で本発明を
詳細に説明するが本発明はこれらによって限定されるも
のではない。
Hereinafter, the present invention will be described in detail with reference to Reference Examples, Examples and Test Examples, but the present invention is not limited thereto.

【0066】[0066]

【実施例】【Example】

参考例1 Reference example 1

【0067】[0067]

【化23】 Embedded image

【0068】アルゴン気流中、室温で文献[F.Bel
lamy and J.Streith J.Che
m.Res.(S)18(1979)およびJ.Che
m.Res.(M)0101(1979)]記載の方法
によって合成した3−クロロ−2−ホルミルピロ−ル
(130mg,1.00mmol)とトリエチルアミン
(0.42mL,3.0mmol)のアセトニトリル
(10mL)溶液に塩化p−トルエンスルホニル(28
7mg,1.50mmol)を加え室温で20時間かき
まぜた。反応混合物を飽和食塩水中にあけエーテルで3
回抽出した。有機層を集め硫酸マグネシウムで乾燥した
のちエバポレ−タで濃縮した。残渣をシリカゲル薄層ク
ロマトグラフィ(ヘキサン/酢酸エチル 9:1−4:
1)で精製して3−クロロ−2−ホルミル−1−p−ト
ルエンスルホニルピロ−ル(278mg,0.979m
mol)を98%の収率で得た。
Reference [F. Bel
lamy and J. Street J. Che
m. Res. (S) 18 (1979) and J. Che
m. Res. (M) 0101 (1979)], a mixture of 3-chloro-2-formylpyrrole (130 mg, 1.00 mmol) and triethylamine (0.42 mL, 3.0 mmol) in acetonitrile (10 mL) was added with p chloride. -Toluenesulfonyl (28
7 mg, 1.50 mmol) was added and the mixture was stirred at room temperature for 20 hours. The reaction mixture is poured into saturated saline and the mixture is washed with ether.
Extracted times. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate 9: 1-4:
1-) and purified by 3-chloro-2-formyl-1-p-toluenesulfonylpyrrole (278 mg, 0.979 m
mol) was obtained with a yield of 98%.

【0069】TLC Rf 0.33(ヘキサン/酢酸
エチル 4:1). 融点 74〜75℃.1 HNMRスペクトル (200MHz,CDCl3)δ
2.43(s,3H),6.39(d,J=3.3H
z,1H),7.34(br d,J=8.1Hz,2
H),7.68(d,J=3.2Hz,1H),7.8
6(br d,J=8.4Hz,2H),9.89
(s,1H). IRスペクトル (neat) 3430(br,
m),2920(m),1720(s),1680
(s),1380(s),1175(s),1120
(w),1035(m),810(m),665(m)
cm-1. 低分解能 MS m/e(相対比) 285(M,
1),283(M,2),221(4),219(1
1),155(31),91(100). 元素分析 (C1210ClNO3S) 計算値: C;
50.80,H;3.55,N;4.94,S;11.
30,Cl;12.50, 実測値: C;50.8
0,H;3.35,N;4.98,S;11.15,C
l;12.50.
TLC R f 0.33 (hexane / ethyl acetate 4: 1). Melting point 74-75 [deg.] C. 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
2.43 (s, 3H), 6.39 (d, J = 3.3H
z, 1H), 7.34 (br d, J = 8.1 Hz, 2
H), 7.68 (d, J = 3.2 Hz, 1H), 7.8
6 (br d, J = 8.4 Hz, 2H), 9.89
(S, 1H). IR spectrum (neat) 3430 (br,
m), 2920 (m), 1720 (s), 1680
(S), 1380 (s), 1175 (s), 1120
(W), 1035 (m), 810 (m), 665 (m)
cm -1 . Low resolution MS m / e (relative ratio) 285 (M,
1), 283 (M, 2), 221 (4), 219 (1
1), 155 (31), 91 (100). Elemental analysis (C 12 H 10 ClNO 3 S) calculated: C;
50.80, H; 3.55, N; 4.94, S; 11.
30, Cl; 12.50, found: C; 50.8
0, H; 3.35, N; 4.98, S; 11.15, C
1; 12.50.

【0070】参考例2Reference Example 2

【0071】[0071]

【化24】 Embedded image

【0072】アルゴン気流中、−78℃で3−クロロ−
2−ホルミル−1−p−トルエンスルホニルピロ−ル
(709mg,2.50mmol)のTHF(25m
L)溶液に臭化メチルマグネシウムの3.0Mエチルエ
−テル溶液(1.00mL,3.0mmol)を加え−
78℃で2時間、室温でさらに16時間かきまぜた。反
応混合物を飽和塩化アンモニウム水中にあけエ−テルで
3回抽出した。有機層を集め硫酸マグネシウムで乾燥し
たのちエバポレ−タで濃縮した。残渣をシリカゲルフラ
ッシュクロマトグラフィ(ヘキサン/酢酸エチル 9:
1)で精製して3−クロロ−2−(1−ヒドロキシエチ
ル)−1−p−トルエンスルホニルピロ−ル(632m
g,2.11mmol)を84%の収率で得た。
3-chloro-at -78 ° C in an argon stream.
2-Formyl-1-p-toluenesulfonylpyrrole (709 mg, 2.50 mmol) in THF (25 m
L) To the solution was added a 3.0 M solution of methylmagnesium bromide in ethyl ether (1.00 mL, 3.0 mmol)-
The mixture was stirred at 78 ° C. for 2 hours and at room temperature for 16 hours. The reaction mixture was poured into saturated ammonium chloride water and extracted with ether three times. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was flash chromatographed on silica gel (hexane / ethyl acetate 9:
1) and purified by 3-chloro-2- (1-hydroxyethyl) -1-p-toluenesulfonylpyrrole (632m
g, 2.11 mmol) was obtained with a yield of 84%.

【0073】TLC Rf 0.49(ヘキサン/酢酸
エチル 4:1).1 HNMRスペクトル (200MHz,CDCl3)δ
1.56(d,J=6.7Hz,3H),2.42
(s,3H),2.74(d,J=8.4Hz,1
H),5.28(dq,Jd=8.3,Jq=6.8H
z,1H),6.21(d,J=3.5Hz,1H),
7.20(d,J=3.5Hz,1H),7.32
(d,J=8.1Hz,2H),7.69(d,J=
8.5Hz,2H). IRスペクトル (neat) 3555(w),34
30(br w),3154(w),2978(w),
2932(w),1582(m),1370(s),1
208(m),1177(vs),1138(m),1
086(m),1034(w),999(w),920
(br w),814(w),714(m),673
(s)cm-1. 低分解能 MS m/e(相対比) 301(M,
3),299(M,10),286(9),284(2
4),291(6),155(29),128(3
3),91(100).
TLC R f 0.49 (hexane / ethyl acetate 4: 1). 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
1.56 (d, J = 6.7 Hz, 3H), 2.42
(S, 3H), 2.74 (d, J = 8.4Hz, 1
H), 5.28 (dq, Jd = 8.3, Jq = 6.8H
z, 1H), 6.21 (d, J = 3.5Hz, 1H),
7.20 (d, J = 3.5 Hz, 1H), 7.32
(D, J = 8.1 Hz, 2H), 7.69 (d, J =
8.5 Hz, 2H). IR spectrum (neat) 3555 (w), 34
30 (br w), 3154 (w), 2978 (w),
2932 (w), 1582 (m), 1370 (s), 1
208 (m), 1177 (vs), 1138 (m), 1
086 (m), 1034 (w), 999 (w), 920
(Br w), 814 (w), 714 (m), 673
(S) cm -1 . Low resolution MS m / e (relative ratio) 301 (M,
3), 299 (M, 10), 286 (9), 284 (2
4), 291 (6), 155 (29), 128 (3
3), 91 (100).

【0074】参考例3Reference Example 3

【0075】[0075]

【化25】 Embedded image

【0076】アルゴン気流中、室温で3−クロロ−2−
(1−ヒドロキシエチル)−1−p−トルエンスルホニ
ルピロ−ル(116mg,0.386mmol)のジク
ロロメタン(4mL)溶液に1,1,1−トリアセトキ
シ−1,1−ジヒドロ−1,2−ベンズヨ−ドキソ−ル
−3(1H)−オン(327mg,0.771mmo
l)を加え室温で30分間かきまぜた。10%チオ硫酸
ナトリウム水を加え激しくかきまぜたのち、反応混合物
を飽和食塩水中にあけエ−テルで3回抽出した。有機層
を集め硫酸マグネシウムで乾燥したのちエバポレ−タで
濃縮した。残渣をシリカゲルフラッシュクロマトグラフ
ィ(ヘキサン/酢酸エチル 9:1)で精製して2−ア
セチル−3−クロロ−1−p−トルエンスルホニルピロ
−ル(109mg,0.365mmol)を95%の収
率で得た。
3-chloro-2- at room temperature in an argon stream.
A solution of (1-hydroxyethyl) -1-p-toluenesulfonylpyrrole (116 mg, 0.386 mmol) in dichloromethane (4 mL) was added to 1,1,1-triacetoxy-1,1-dihydro-1,2-benzyo. -Doxole-3 (1H) -one (327 mg, 0.771 mmo
1) was added and the mixture was stirred at room temperature for 30 minutes. After 10% aqueous sodium thiosulfate was added and the mixture was vigorously stirred, the reaction mixture was poured into saturated saline and extracted three times with ether. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was purified by silica gel flash chromatography (hexane / ethyl acetate 9: 1) to give 2-acetyl-3-chloro-1-p-toluenesulfonylpyrrole (109 mg, 0.365 mmol) in 95% yield. It was

【0077】TLC Rf 0.40(ヘキサン/酢酸
エチル 4:1). 融点 117℃.1 HNMRスペクトル (200MHz,CDCl3)δ
2.42(s,3H),2.54(s,3H),6.
32(d,J=3.5Hz,1H),7.33(d,J
=8.1Hz,2H),7.70(d,J=3.5H
z,1H),7.86(d,J=8.5Hz,2H). IRスペクトル (neat) 3145(w),29
20(s),2850(m),1670(s),159
0(w),1520(w),1435(m),1400
(s),1360(s),1310(m),1230
(m),1205(m),1170(s),1130
(s),1080(m),1010(m),920
(w),815(m)cm-1. 低分解能 MS m/e(相対比) 299(M,
2),297(M,4),282(0.6),235
(7),233(19),220(3),218
(8),155(38),91(100). 元素分析 (C1312ClNO3S) 計算値: C;
52.44,H;4.06,N;4.70,S;10.
77,Cl;11.91, 実測値: C;52.4
7,H;4.06,N;4.60,S;10.61,C
l;11.89.
TLC R f 0.40 (hexane / ethyl acetate 4: 1). Melting point 117 [deg.] C. 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
2.42 (s, 3H), 2.54 (s, 3H), 6.
32 (d, J = 3.5 Hz, 1 H), 7.33 (d, J
= 8.1 Hz, 2H), 7.70 (d, J = 3.5H)
z, 1H), 7.86 (d, J = 8.5Hz, 2H). IR spectrum (neat) 3145 (w), 29
20 (s), 2850 (m), 1670 (s), 159
0 (w), 1520 (w), 1435 (m), 1400
(S), 1360 (s), 1310 (m), 1230
(M), 1205 (m), 1170 (s), 1130
(S), 1080 (m), 1010 (m), 920
(W), 815 (m) cm -1 . Low resolution MS m / e (relative ratio) 299 (M,
2), 297 (M, 4), 282 (0.6), 235
(7), 233 (19), 220 (3), 218
(8), 155 (38), 91 (100). Elemental analysis (C 13 H 12 ClNO 3 S) calculated: C;
52.44, H; 4.06, N; 4.70, S; 10.
77, Cl; 11.91, found: C; 52.4.
7, H; 4.06, N; 4.60, S; 10.61, C
1; 11.89.

【0078】参考例4Reference Example 4

【0079】[0079]

【化26】 [Chemical formula 26]

【0080】アルゴン気流中、−78℃でジイソプロピ
ルアミン(1.05mL,7.14mmol)のTHF
溶液(35mL)にn−ブチルリチウムの1.7Mヘキ
サン溶液(4.1mL,7.0mmol)を加え−78
℃で5分間、0℃でさらに20分間かきまぜた。−78
℃に冷却したのち2−アセチル−3−クロロ−1−p−
トルエンスルホニルピロ−ル(1.06g,3.56m
mol)のTHF溶液(2mL)を加え−78℃で1時
間かきまぜた。(テトラヒドロ−2−ピラニルオキシ)
アセトアルデヒド(1.01g,7.01mmol)の
THF(2mL)溶液を加え−78℃でさらに1.5時
間かきまぜた。冷反応混合物を飽和塩化アンモニウム水
中にあけエ−テルで3回抽出した。有機層を集め硫酸マ
グネシウムで乾燥したのちエバポレ−タで濃縮した。残
渣をシリカゲルフラッシュクロマトグラフィ(ヘキサン
/酢酸エチル 2:1)で精製して3−クロロ−2−
[3−ヒドロキシ−1−オキソ−4−(テトラヒドロ−
2−ピラニルオキシ)ブチル]−1−p−トルエンスル
ホニルピロ−ル(851mg,1.93mmol)を5
4%の収率で原料の2−アセチル−3−クロロ−1−p
−トルエンスルホニルピロ−ル(0.15g,0.50
mmol)とともに得た。
Diisopropylamine (1.05 mL, 7.14 mmol) in THF at −78 ° C. in an argon stream.
To the solution (35 mL) was added a 1.7 M hexane solution of n-butyllithium (4.1 mL, 7.0 mmol), and -78 was added.
The mixture was stirred at 0 ° C for 5 minutes and at 0 ° C for another 20 minutes. -78
After cooling to ℃, 2-acetyl-3-chloro-1-p-
Toluenesulfonyl pyrrole (1.06g, 3.56m
THF solution (2 mL) of (mol) was added and stirred at -78 ° C for 1 hour. (Tetrahydro-2-pyranyloxy)
A solution of acetaldehyde (1.01 g, 7.01 mmol) in THF (2 mL) was added, and the mixture was further stirred at -78 ° C for 1.5 hr. The cold reaction mixture was poured into saturated ammonium chloride water and extracted three times with ether. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was purified by silica gel flash chromatography (hexane / ethyl acetate 2: 1) to give 3-chloro-2-
[3-hydroxy-1-oxo-4- (tetrahydro-
2-pyranyloxy) butyl] -1-p-toluenesulfonylpyrrole (851 mg, 1.93 mmol) was added to 5
Starting material 2-acetyl-3-chloro-1-p with a yield of 4%
-Toluenesulfonylpyrrole (0.15 g, 0.50
mmol).

【0081】TLC Rf 0.59(ヘキサン/酢酸
エチル 1:1).1 HNMRスペクトル (200MHz,CDCl3)δ
1.46〜1.80(m,6H),2.43(s,3
H),3.12〜3.19(m,2H),3.46〜
3.93(m,4H),4.26〜4.38(m,1
H),4.56〜4.64(m,1H),6.31
(d,J=3.4Hz,1H),7.33(d,J=
8.2Hz,2H),7.66(d,J=3.4Hz,
1H),7.86(d,J=8.3Hz,2H). IRスペクトル (neat) 3420(br
m),3145(w),2930(s),2860
(w),1670(s),1590(w),1520
(m),1415(m),1400(m),1365
(s),1170(vs),1125(s),1030
(s),970(m),900(w),810(m)c
-1. 低分解能 MS m/e(相対比) 357(M−DH
P,1),340(3),322(5),286
(4),284(4),256(4),202(5),
186(6),155(19),91(57),85
(100). CI−MS m/e 442(M+1).
TLC R f 0.59 (hexane / ethyl acetate 1: 1). 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
1.46-1.80 (m, 6H), 2.43 (s, 3
H), 3.12 to 3.19 (m, 2H), 3.46 to
3.93 (m, 4H), 4.26 to 4.38 (m, 1
H), 4.56 to 4.64 (m, 1H), 6.31
(D, J = 3.4 Hz, 1H), 7.33 (d, J =
8.2Hz, 2H), 7.66 (d, J = 3.4Hz,
1H), 7.86 (d, J = 8.3 Hz, 2H). IR spectrum (neat) 3420 (br
m), 3145 (w), 2930 (s), 2860
(W), 1670 (s), 1590 (w), 1520
(M), 1415 (m), 1400 (m), 1365
(S), 1170 (vs), 1125 (s), 1030
(S), 970 (m), 900 (w), 810 (m) c
m -1 . Low resolution MS m / e (relative ratio) 357 (M-DH
P, 1), 340 (3), 322 (5), 286
(4), 284 (4), 256 (4), 202 (5),
186 (6), 155 (19), 91 (57), 85
(100). CI-MS m / e 442 (M + 1).

【0082】参考例5Reference Example 5

【0083】[0083]

【化27】 Embedded image

【0084】アルゴン気流中、室温で3−クロロ−2−
[3−ヒドロキシ−1−オキソ−4−(テトラヒドロ−
2−ピラニルオキシ)ブチル]−1−p−トルエンスル
ホニルピロ−ル(176mg,0.398mmol)の
ジクロロメタン(8mL)溶液に1,1,1−トリアセ
トキシ−1,1−ジヒドロ−1,2−ベンズヨ−ドキソ
−ル−3(1H)−オン(212mg,0.500mm
ol)を1時間かけて少量ずつ加え室温でさらに1時間
かきまぜた。10%チオ硫酸ナトリウム水を加え激しく
かきまぜたのち、反応混合物を飽和食塩水中にあけエ−
テルで3回抽出した。有機層を集め硫酸マグネシウムで
乾燥したのちエバポレ−タで濃縮した。残渣をシリカゲ
ル薄層クロマトグラフィ(ヘキサン/酢酸エチル 2:
1)で精製して3−クロロ−2−[1,3−ジオキソ−
4−(テトラヒドロ−2−ピラニルオキシ)ブチル]−
1−p−トルエンスルホニルピロ−ル(106mg,
0.240mmol)を60%の収率で得た。
3-chloro-2- at room temperature in an argon stream.
[3-hydroxy-1-oxo-4- (tetrahydro-
2-Pyranyloxy) butyl] -1-p-toluenesulfonylpyrrole (176 mg, 0.398 mmol) in dichloromethane (8 mL) solution was added to 1,1,1-triacetoxy-1,1-dihydro-1,2-benzyo. -Doxole-3 (1H) -one (212 mg, 0.500 mm
ol) was added little by little over 1 hour, and the mixture was stirred at room temperature for 1 hour. After 10% aqueous sodium thiosulfate was added and the mixture was vigorously stirred, the reaction mixture was poured into saturated saline and air-cooled.
Extracted 3 times with tel. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate 2:
After purification in 1), 3-chloro-2- [1,3-dioxo-
4- (tetrahydro-2-pyranyloxy) butyl]-
1-p-toluenesulfonylpyrrole (106 mg,
0.240 mmol) was obtained in a yield of 60%.

【0085】TLC Rf 0.50(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,CDCl3)δ
1.46〜1.93(m,6H),2.44(s,3
H),3.49〜3.59(m,1H),3.79〜
3.90(m,1H),4.16(d,J=17.0H
z,1H),4.35(d,J=16.6Hz,1
H),4.71〜4.73(br s,1H),6.3
2(d,J=3.5Hz,1H),6.41(s,1
H),7.33(d,J=8.1Hz,2H),7.5
8(d,J=3.5Hz,1H),7.86(d,J=
8.4Hz,2H). IRスペクトル (neat) 3150(br
w),2940(m),1735(w),1595(b
r s),1370(m),1175(s),1125
(s),1080(s),1035(m),810
(m)cm-1. 低分解能 MS m/e(相対比) 355(M−DH
P,4),324(16),320(10),297
(3),282(4),184(7),155(4
0),128(13),91(62),85(10
0). CI−MS m/e 440(M+1).
TLC R f 0.50 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
1.46-1.93 (m, 6H), 2.44 (s, 3
H), 3.49 to 3.59 (m, 1H), 3.79 to
3.90 (m, 1H), 4.16 (d, J = 17.0H
z, 1H), 4.35 (d, J = 16.6 Hz, 1
H), 4.71 to 4.73 (brs, 1H), 6.3.
2 (d, J = 3.5Hz, 1H), 6.41 (s, 1
H), 7.33 (d, J = 8.1 Hz, 2H), 7.5
8 (d, J = 3.5 Hz, 1 H), 7.86 (d, J =
8.4 Hz, 2H). IR spectrum (neat) 3150 (br
w), 2940 (m), 1735 (w), 1595 (b
rs), 1370 (m), 1175 (s), 1125
(S), 1080 (s), 1035 (m), 810
(M) cm -1 . Low resolution MS m / e (relative ratio) 355 (M-DH
P, 4), 324 (16), 320 (10), 297.
(3), 282 (4), 184 (7), 155 (4
0), 128 (13), 91 (62), 85 (10
0). CI-MS m / e 440 (M + 1).

【0086】参考例6Reference Example 6

【0087】[0087]

【化28】 Embedded image

【0088】アルゴン気流中、室温で3−クロロ−2−
[1,3−ジオキソ−4−(テトラヒドロ−2−ピラニ
ルオキシ)ブチル]−1−p−トルエンスルホニルピロ
−ル(93.9mg,0.213mmol)のメタノ−
ル(2.1mL)溶液にカンファースルホン酸(9.9
mg,0.043mmol)を加え室温で13時間かき
まぜた。反応混合物を飽和炭酸水素ナトリウム水中にあ
けエ−テルで3回抽出した。有機層を集め硫酸マグネシ
ウムで乾燥したのちエバポレ−タで濃縮した。残渣をシ
リカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3
−クロロ−1−p−トルエンスルホニル−2−ピロリ
ル)−3−メトキシフラン(56.7mg,0.161
mmol)を76%の収率で得た。
3-chloro-2- at room temperature in an argon stream.
Methanol of [1,3-dioxo-4- (tetrahydro-2-pyranyloxy) butyl] -1-p-toluenesulfonylpyrrole (93.9 mg, 0.213 mmol)
Solution (2.1 mL) with camphorsulfonic acid (9.9
(mg, 0.043 mmol) was added and the mixture was stirred at room temperature for 13 hours. The reaction mixture was poured into saturated sodium hydrogen carbonate water and extracted with ether three times. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 5- (3
-Chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (56.7 mg, 0.161
mmol) was obtained in a yield of 76%.

【0089】TLC Rf 0.62(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.72(s,3H),3.16(s,3H),5.9
0(d,J=3.5Hz,1H),6.43(br
s,1H),6.53(d,J=8.2Hz,2H),
6.83(d,J=0.9Hz,1H),7.21
(d,J=3.6Hz,1H),7.45(d,J=
8.4Hz,2H). IRスペクトル (neat) 3680〜3230
(br w),2920(m),2360(w),17
20(w),1635(m),1570(m),145
5(m),1380(s),1300(w),1265
(m),1205(w),1170(s),1130
(s),1080(w),1050(m),1025
(s),980(w),890(m),800(m)c
-1. 低分解能 MS m/e(相対比) 353(M,1
1),351(M,28),198(34),196
(100),155(9),153(19),125
(8),91(23). 高分解能 MS (C1614ClNO4S) 計算値:
351.0331,実測値: 351.0317.
(C1614Cl*NO4S) 計算値: 353.030
1, 実測値: 353.0280.
TLC R f 0.62 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.72 (s, 3H), 3.16 (s, 3H), 5.9
0 (d, J = 3.5 Hz, 1 H), 6.43 (br
s, 1H), 6.53 (d, J = 8.2Hz, 2H),
6.83 (d, J = 0.9 Hz, 1H), 7.21
(D, J = 3.6 Hz, 1H), 7.45 (d, J =
8.4 Hz, 2H). IR spectrum (neat) 3680-3230
(Br w), 2920 (m), 2360 (w), 17
20 (w), 1635 (m), 1570 (m), 145
5 (m), 1380 (s), 1300 (w), 1265
(M), 1205 (w), 1170 (s), 1130
(S), 1080 (w), 1050 (m), 1025
(S), 980 (w), 890 (m), 800 (m) c
m -1 . Low resolution MS m / e (relative ratio) 353 (M, 1
1), 351 (M, 28), 198 (34), 196.
(100), 155 (9), 153 (19), 125
(8), 91 (23). High resolution MS (C 16 H 14 ClNO 4 S) Calculated value:
351.0331, measured value: 351.0317.
(C 16 H 14 Cl * NO 4 S) Calculated: 353.030
1, measured value: 353.0280.

【0090】参考例7Reference Example 7

【0091】[0091]

【化29】 [Chemical 29]

【0092】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(26.9mg,0.0765mmo
l)のメタノ−ル(0.8mL)溶液に炭酸カリウム
(106mg,0.767mmol)を加え室温で23
時間かきまぜた。反応混合物を飽和食塩水中にあけエー
テルで3回抽出した。有機層を集め硫酸マグネシウムで
乾燥したのちエバポレ−タで濃縮した。残渣をシリカゲ
ル薄層クロマトグラフィ(ヘキサン/酢酸エチル2:
1,1%トリエチルアミン)で精製して5−(3−クロ
ロ−2−ピロリル)−3−メトキシフラン(10.8m
g,0.0547mmol)を71%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in an argon stream.
Methoxyfuran (26.9 mg, 0.0765 mmo
To a solution of 1) in methanol (0.8 mL) was added potassium carbonate (106 mg, 0.767 mmol), and the mixture was stirred at room temperature for 23 hours.
Stir the time. The reaction mixture was poured into saturated saline and extracted 3 times with ether. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate 2:
Purification with 1,1% triethylamine) and 5- (3-chloro-2-pyrrolyl) -3-methoxyfuran (10.8m
g, 0.0547 mmol) was obtained in a yield of 71%.

【0093】TLC Rf 0.51(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
3.25(s,3H),5.92(t,J=3.0H
z,1H),6.08(t,J=3.0Hz,1H),
6.78(d,J=0.9Hz,1H),6.81
(d,J=0.8Hz,1H),7.28〜7.62
(br,1H). IRスペクトル (neat) 3420(br
m),2920(w),2350(w),2330
(w),1625(m),1575(m),1530
(w),1380(m),1250(w),1100
(w),1060(w),1030(m),960
(w),880(w)cm-1. 低分解能 MS m/e(相対比) 199(M,3
4),197(M,100),156(22),154
(68),128(11),126(34),91(2
0). 高分解能 MS (C98ClNO2) 計算値: 1
97.0243, 実測値: 197.0231.
(C98Cl*NO2) 計算値: 199.0213,
実測値: 199.0216.
TLC R f 0.51 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
3.25 (s, 3H), 5.92 (t, J = 3.0H
z, 1H), 6.08 (t, J = 3.0Hz, 1H),
6.78 (d, J = 0.9 Hz, 1H), 6.81
(D, J = 0.8 Hz, 1H), 7.28 to 7.62
(Br, 1H). IR spectrum (neat) 3420 (br
m), 2920 (w), 2350 (w), 2330
(W), 1625 (m), 1575 (m), 1530
(W), 1380 (m), 1250 (w), 1100
(W), 1060 (w), 1030 (m), 960
(W), 880 (w) cm -1 . Low resolution MS m / e (relative ratio) 199 (M, 3
4), 197 (M, 100), 156 (22), 154
(68), 128 (11), 126 (34), 91 (2
0). High resolution MS (C 9 H 8 ClNO 2 ) Calculated value: 1
97.0243, found: 197.0231.
(C 9 H 8 Cl * NO 2) Calculated: 199.0213,
Found: 199.0216.

【0094】実施例1Example 1

【0095】[0095]

【化30】 Embedded image

【0096】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(17.8mg,0.0506mmo
l)のメタノ−ル(0.5mL)溶液に炭酸カリウム
(35.0mg,0.253mmol)を加え室温で1
7時間かきまぜた。TLCで5−(3−クロロ−2−ピ
ロリル)−3−メトキシフランの生成を確認した後、シ
クロヘキサンカルボキシアルデヒド(30.6μL,
0.253mmol)を加え室温でさらに11時間かき
まぜた。反応混合物を減圧下に濃縮し、残渣をシリカゲ
ル薄層クロマトグラフィ(ヘキサン/酢酸エチル 2:
1,1%トリエチルアミン)で精製して5−(3−クロ
ロ−2−ピロリル)−2−(シクロヘキシルヒドロキシ
メチル)−3−メトキシフラン(8.1mg,0.02
6mmol)を52%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in an argon stream.
Methoxyfuran (17.8mg, 0.0506mmo
potassium carbonate (35.0 mg, 0.253 mmol) was added to a methanol (0.5 mL) solution of 1) at room temperature.
Stir for 7 hours. After confirming the formation of 5- (3-chloro-2-pyrrolyl) -3-methoxyfuran by TLC, cyclohexanecarboxaldehyde (30.6 μL,
0.253 mmol) was added and the mixture was stirred at room temperature for 11 hours. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2:
Purification with 1,1% triethylamine) and 5- (3-chloro-2-pyrrolyl) -2- (cyclohexylhydroxymethyl) -3-methoxyfuran (8.1 mg, 0.02
6 mmol) was obtained with a yield of 52%.

【0097】TLC Rf 0.43(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
0.97〜2.10(m,11H),2.29(br,
1H),3.31(s,3H),4.59(d,J=
8.4Hz,1H),6.10(t,J=2.9Hz,
1H),6.15(t,J=2.9Hz,1H),6.
73(s,1H),8.37(br,1H). IRスペクトル (neat) 3650〜3070
(br m),2920(vs),2850(m),1
715(w),1635(s),1600(w),15
25(m),1445(m),1385(m),123
0(m),1100(m),1050(s),985
(m),880(m),780(m),720(m)c
-1. 低分解能 MS m/e(相対比) 311(M,
1),309(M,4),293(34),291(1
00),228(20),226(57),212(1
3),210(32),197(12),163(1
9),128(43). 高分解能 MS (C1620ClNO3) 計算値:
309.1130, 実測値: 309.1111.
(C1620Cl*NO3) 計算値: 311.110
0, 実測値: 311.1092.
TLC R f 0.43 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
0.97 to 2.10 (m, 11H), 2.29 (br,
1H), 3.31 (s, 3H), 4.59 (d, J =
8.4 Hz, 1 H), 6.10 (t, J = 2.9 Hz,
1H), 6.15 (t, J = 2.9 Hz, 1H), 6.
73 (s, 1H), 8.37 (br, 1H). IR spectrum (neat) 3650-3070
(Br m), 2920 (vs), 2850 (m), 1
715 (w), 1635 (s), 1600 (w), 15
25 (m), 1445 (m), 1385 (m), 123
0 (m), 1100 (m), 1050 (s), 985
(M), 880 (m), 780 (m), 720 (m) c
m -1 . Low resolution MS m / e (relative ratio) 311 (M,
1), 309 (M, 4), 293 (34), 291 (1
00), 228 (20), 226 (57), 212 (1
3), 210 (32), 197 (12), 163 (1
9), 128 (43). High resolution MS (C 16 H 20 ClNO 3 ) Calculated value:
309.1130, Found: 309.1111.
(C 16 H 20 Cl * NO 3) Calculated: 311.110
0, found: 311.1092.

【0098】実施例2Example 2

【0099】[0099]

【化31】 [Chemical 31]

【0100】アルゴン気流中、室温で5−(3−クロロ
−2−ピロリル)−2−(シクロヘキシルヒドロキシメ
チル)−3−メトキシフラン(12.4mg,0.04
00mmol)のアセトニトリル(0.4mL)溶液に
ジ−tert−ブチルジカルボナート(16.8mg,
0.0770mmol)と4−ジメチルアミノピリジン
(4.3mg,0.038mmol)を加え室温で30
分間かきまぜた。反応混合物を減圧下に濃縮し、残渣を
シリカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチ
ル 4:1,1%トリエチルアミン)で精製して5−
(1−tert−ブトキシカルボニル−3−クロロ−2
−ピロリル)−2−(シクロヘキシルヒドロキシメチ
ル)−3−メトキシフラン(8.9mg,0.022m
mol)を54%の収率で得た。
5- (3-chloro-2-pyrrolyl) -2- (cyclohexylhydroxymethyl) -3-methoxyfuran (12.4 mg, 0.04) at room temperature in a stream of argon.
(00 mmol) in acetonitrile (0.4 mL) was added with di-tert-butyl dicarbonate (16.8 mg,
0.0770 mmol) and 4-dimethylaminopyridine (4.3 mg, 0.038 mmol) were added and the mixture was stirred at room temperature for 30
Stir for a minute. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 4: 1,1% triethylamine) to give 5-
(1-tert-butoxycarbonyl-3-chloro-2
-Pyrrolyl) -2- (cyclohexylhydroxymethyl) -3-methoxyfuran (8.9 mg, 0.022 m
mol) was obtained with a yield of 54%.

【0101】TLC Rf 0.40(ヘキサン/酢酸
エチル 4:1).1 HNMRスペクトル (200MHz,C66)δ
0.97〜2.23(m,11H),1.25(s,9
H),3.33(s,3H),4.26(brd,J=
8.0Hz,1H),6.01(d,J=3.5Hz,
1H),6.30(s,1H),7.15(d,J=
3.5Hz,1H). IRスペクトル (neat) 3670〜3040
(br m),2920(s),2850(w),17
40(s),1640(m),1455(m),138
0(m),1365(m),1310(vs),125
0(m),1140(s),1060(w),1015
(m),950(w),840(w),735(w)c
-1. 低分解能 MS m/e(相対比) 411(M,
1),409(M,3),393(4),391(1
0),337(21),335(62),291(1
9),272(12),270(38),228(1
0),226(33),128(15),57(10
0). 高分解能 MS (C2128ClNO5) 計算値:
409.1655, 実測値: 409.1660.
(C2128Cl*NO5) 計算値: 411.162
5, 実測値: 411.1647.
TLC R f 0.40 (hexane / ethyl acetate 4: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
0.97 to 2.23 (m, 11H), 1.25 (s, 9
H), 3.33 (s, 3H), 4.26 (brd, J =
8.0 Hz, 1 H), 6.01 (d, J = 3.5 Hz,
1H), 6.30 (s, 1H), 7.15 (d, J =
3.5 Hz, 1H). IR spectrum (neat) 3670-3040
(Br m), 2920 (s), 2850 (w), 17
40 (s), 1640 (m), 1455 (m), 138
0 (m), 1365 (m), 1310 (vs), 125
0 (m), 1140 (s), 1060 (w), 1015
(M), 950 (w), 840 (w), 735 (w) c
m -1 . Low resolution MS m / e (relative ratio) 411 (M,
1), 409 (M, 3), 393 (4), 391 (1
0), 337 (21), 335 (62), 291 (1
9), 272 (12), 270 (38), 228 (1
0), 226 (33), 128 (15), 57 (10
0). High resolution MS (C 21 H 28 ClNO 5 ) Calculated value:
409.1655, found: 409.1660.
(C 21 H 28 Cl * NO 5 ) calculated: 411.162
5, measured value: 411.1647.

【0102】実施例3Example 3

【0103】[0103]

【化32】 Embedded image

【0104】アルゴン気流中、0℃で5−(1−ter
t−ブトキシカルボニル−3−クロロ−2−ピロリル)
−2−(シクロヘキシルヒドロキシメチル)−3−メト
キシフラン(4.4mg,0.0107mmol)のジ
クロロメタン(0.5mL)溶液にトリエチルアミン
(7.5μL,0.054mmol)を加え、続いてメ
タンスルホニルクロリド(2.0μL,0.026mm
ol)を加え0℃で20分間、室温でさらに40分間か
きまぜた。反応混合物を減圧下に濃縮し、残渣をシリカ
ゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
4:1,1%トリエチルアミン)で精製して5−(1−
tert−ブトキシカルボニル−3−クロロ−2−ピロ
リル)−2−(シクロヘキシリデンメチル)−3−メト
キシフラン(3.4mg,0.0087mmol)を8
1%の収率で得た。
5- (1-ter) at 0 ° C. in an argon stream.
t-butoxycarbonyl-3-chloro-2-pyrrolyl)
Triethylamine (7.5 μL, 0.054 mmol) was added to a solution of 2- (cyclohexylhydroxymethyl) -3-methoxyfuran (4.4 mg, 0.0107 mmol) in dichloromethane (0.5 mL), followed by methanesulfonyl chloride ( 2.0 μL, 0.026 mm
ol) was added and the mixture was stirred at 0 ° C. for 20 minutes and at room temperature for 40 minutes. The reaction mixture was concentrated under reduced pressure and the residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
Purify with 4: 1, 1% triethylamine) to give 5- (1-
tert-Butoxycarbonyl-3-chloro-2-pyrrolyl) -2- (cyclohexylidenemethyl) -3-methoxyfuran (3.4 mg, 0.0087 mmol) was added to 8
Obtained in a yield of 1%.

【0105】TLC Rf 0.57(ヘキサン/酢酸
エチル 4:1).1 HNMRスペクトル (200MHz,C66)δ
1.27(s,9H),1.30〜1.55(m,6
H),2.15(br t,J=6Hz,2H),2.
74(br t,J=6Hz,2H),3.35(s,
3H),5.99(d,J=3.5Hz,1H),6.
31(br s,1H),6.32(s,1H),7.
25(d,J=3.5Hz,1H). IRスペクトル (neat) 2920(m),17
40(s),1560(w),1455(w),136
5(w),1310(vs),1250(w),114
0(s),1105(w),1055(w),1015
(w),950(w)cm-1. 低分解能 MS m/e(相対比) 393(M,
6),391(M,17),337(34),335
(100),293(9),291(26),212
(5),210(15),128(22),57(9
6). 高分解能 MS (C2126ClNO4) 計算値:
391.1548, 実測値: 391.1537.
(C2126Cl*NO4) 計算値: 393.151
9, 実測値: 393.1547.
TLC R f 0.57 (hexane / ethyl acetate 4: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.27 (s, 9H), 1.30 to 1.55 (m, 6
H), 2.15 (brt, J = 6 Hz, 2H), 2.
74 (br t, J = 6 Hz, 2H), 3.35 (s,
3H), 5.99 (d, J = 3.5Hz, 1H), 6.
31 (br s, 1H), 6.32 (s, 1H), 7.
25 (d, J = 3.5 Hz, 1H). IR spectrum (neat) 2920 (m), 17
40 (s), 1560 (w), 1455 (w), 136
5 (w), 1310 (vs), 1250 (w), 114
0 (s), 1105 (w), 1055 (w), 1015
(W), 950 (w) cm -1 . Low resolution MS m / e (relative ratio) 393 (M,
6), 391 (M, 17), 337 (34), 335.
(100), 293 (9), 291 (26), 212
(5), 210 (15), 128 (22), 57 (9
6). High resolution MS (C 21 H 26 ClNO 4 ) Calculated value:
391.1548, Found: 391.1537.
(C 21 H 26 Cl * NO 4) Calculated: 393.151
9, measured value: 393.1547.

【0106】実施例4Example 4

【0107】[0107]

【化33】 [Chemical 33]

【0108】アルゴン気流中、室温で5−(1−ter
t−ブトキシカルボニル−3−クロロ−2−ピロリル)
−2−(シクロヘキシリデンメチル)−3−メトキシフ
ラン(3.4mg,0.0087mmol)のメタノー
ル(0.2mL)溶液に炭酸カリウム(12.0mg,
0.087mmol)を加え室温で1.5時間かきまぜ
た。反応混合物を減圧下に濃縮し、残渣をシリカゲル薄
層クロマトグラフィ(ヘキサン/酢酸エチル 4:1,
1%トリエチルアミン)で精製して5−(3−クロロ−
2−ピロリル)−2−(シクロヘキシリデンメチル)−
3−メトキシフラン(1.92mg,0.0066mm
ol)を76%の収率で得た。
5- (1-ter) at room temperature in an argon stream.
t-butoxycarbonyl-3-chloro-2-pyrrolyl)
2- (Cyclohexylidenemethyl) -3-methoxyfuran (3.4 mg, 0.0087 mmol) in methanol (0.2 mL) solution was added with potassium carbonate (12.0 mg,
0.087 mmol) was added and the mixture was stirred at room temperature for 1.5 hours. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 4: 1,
Purified with 1% triethylamine) and 5- (3-chloro-
2-pyrrolyl) -2- (cyclohexylidenemethyl)-
3-Methoxyfuran (1.92 mg, 0.0066 mm
was obtained in a yield of 76%.

【0109】TLC Rf 0.46(ヘキサン/酢酸
エチル 4:1).1 HNMRスペクトル (200MHz,C66)δ
1.44〜1.73(m,6H),2.23(br
t,J=6Hz,2H),2.76(br t,J=6
Hz,2H),3.33(s,3H),5.88(t,
J=3.0Hz,1H),6.13(t,J=3.0H
z,1H),6.31(br s,1H),6.74
(s,1H),7.56(br s,1H). IRスペクトル (neat) 3650〜3050
(br m),2920(s),2850(w),16
15(m),1565(m),1455(m),138
0(m),1105(m),1060(m),1015
(m),880(w)cm-1. 低分解能 MS m/e(相対比) 293(M,
4),291(M,12),238(3),236
(7),212(6),210(14),199
(3),197(8),163(11),128(2
0). 高分解能 MS (C1618ClNO2) 計算値:
291.1024, 実測値: 291.0992.
TLC R f 0.46 (hexane / ethyl acetate 4: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.44-1.73 (m, 6H), 2.23 (br
t, J = 6 Hz, 2H), 2.76 (br t, J = 6)
Hz, 2H), 3.33 (s, 3H), 5.88 (t,
J = 3.0Hz, 1H), 6.13 (t, J = 3.0H
z, 1H), 6.31 (br s, 1H), 6.74
(S, 1H), 7.56 (br s, 1H). IR spectrum (neat) 3650-3050
(Br m), 2920 (s), 2850 (w), 16
15 (m), 1565 (m), 1455 (m), 138
0 (m), 1105 (m), 1060 (m), 1015
(M), 880 (w) cm -1 . Low resolution MS m / e (relative ratio) 293 (M,
4), 291 (M, 12), 238 (3), 236
(7), 212 (6), 210 (14), 199
(3), 197 (8), 163 (11), 128 (2
0). High resolution MS (C 16 H 18 ClNO 2 ) Calculated value:
291.1024, measured value: 291.0992.

【0110】実施例5Example 5

【0111】[0111]

【化34】 Embedded image

【0112】5−(3−クロロ−1−p−トルエンスル
ホニル−2−ピロリル)−3−メトキシフラン(14.
2mg,0.0404mmol)、シクロヘキサノン
(0.084mL,0.81mmol)、炭酸カリウム
(27.9mg,0.20mmol)、およびメタノー
ル(0.4mL)の混合物を封管中、100℃で17時
間加熱した。反応混合物を減圧下に濃縮し、残渣をシリ
カゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3−
クロロ−2−ピロリル)−2−(1−シクロヘキセニ
ル)−3−メトキシフラン(3.8mg,0.0136
mmol)を34%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (14.
2 mg, 0.0404 mmol), cyclohexanone (0.084 mL, 0.81 mmol), potassium carbonate (27.9 mg, 0.20 mmol), and methanol (0.4 mL) in a sealed tube at 100 ° C. for 17 hours. did. The reaction mixture was concentrated under reduced pressure and the residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
Purify with 2: 1, 1% triethylamine) to give 5- (3-
Chloro-2-pyrrolyl) -2- (1-cyclohexenyl) -3-methoxyfuran (3.8 mg, 0.0136
mmol) was obtained in a yield of 34%.

【0113】TLC Rf 0.61(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.54〜1.76(m,4H),2.17〜2.28
(m,2H),2.54〜2.67(m,2H),3.
30(s,3H),5.99(t,J=3.0Hz,1
H),6.15(t,J=3.0Hz,1H),6.4
6(tt,J=4.2,1.8Hz,1H),6.79
(s,1H),7.56(br,1H). IRスペクトル (neat) 3700〜3050
(br m),2925(m),2850(w),16
15(m),1570(m),1380(s),114
0(w),1095(m),1065(m),1020
(s)cm-1. 低分解能 MS m/e(相対比) 279(M,3
4),277(M,100),264(3),262
(9),251(7),249(21),210(8)
197(8),81(26). 高分解能 MS (C1516ClNO2) 計算値:
277.0868, 実測値: 277.0846.
(C1516Cl*NO2) 計算値: 279.083
9, 実測値: 279.0846.
TLC R f 0.61 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.54 to 1.76 (m, 4H), 2.17 to 2.28
(M, 2H), 2.54 to 2.67 (m, 2H), 3.
30 (s, 3H), 5.99 (t, J = 3.0Hz, 1
H), 6.15 (t, J = 3.0 Hz, 1H), 6.4
6 (tt, J = 4.2, 1.8 Hz, 1H), 6.79
(S, 1H), 7.56 (br, 1H). IR spectrum (neat) 3700 to 3050
(Br m), 2925 (m), 2850 (w), 16
15 (m), 1570 (m), 1380 (s), 114
0 (w), 1095 (m), 1065 (m), 1020
(S) cm -1 . Low resolution MS m / e (relative ratio) 279 (M, 3
4), 277 (M, 100), 264 (3), 262
(9), 251 (7), 249 (21), 210 (8)
197 (8), 81 (26). High resolution MS (C 15 H 16 ClNO 2 ) Calculated value:
277.0868, Found: 277.0846.
(C 15 H 16 Cl * NO 2) Calculated: 279.083
9, measured value: 279.0846.

【0114】実施例6Example 6

【0115】[0115]

【化35】 Embedded image

【0116】5−(3−クロロ−1−p−トルエンスル
ホニル−2−ピロリル)−3−メトキシフラン(12.
5mg,0.0355mmol)、シクロヘプタノン
(0.084mL,0.71mmol)、炭酸カリウム
(24.6mg,0.178mmol)、およびメタノ
ール(0.4mL)の混合物を封管中、100℃で24
時間加熱した。反応混合物を減圧下に濃縮し、残渣をシ
リカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3
−クロロ−2−ピロリル)−2−(1−シクロヘプテニ
ル)−3−メトキシフラン(6.4mg,0.022m
mol)を62%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (12.
5 mg, 0.0355 mmol), cycloheptanone (0.084 mL, 0.71 mmol), potassium carbonate (24.6 mg, 0.178 mmol), and methanol (0.4 mL) in a sealed tube at 100 ° C.
Heated for hours. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 5- (3
-Chloro-2-pyrrolyl) -2- (1-cycloheptenyl) -3-methoxyfuran (6.4 mg, 0.022 m
mol) was obtained in a yield of 62%.

【0117】TLC Rf 0.68(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.51〜1.80(m,6H),2.35(dd,J
=10.9,7.0Hz,2H),2.87〜2.92
(m,2H),3.29(s,3H),5.96(t,
J=3.0Hz,1H),6.14(t,J=3.0H
z,1H),6.69(t,J=7.0Hz,1H),
6.78(s,1H),7.56(br,1H). IRスペクトル (neat) 3720〜3300
(br m),2920(m),2850(w),16
25(m),1600(m),1560(m),144
5(w),1380(m),1100(w),1060
(m),1015(m)cm-1. 低分解能 MS m/e(相対比) 293(M,3
3),291(M,100),278(4),276
(10),265(15),263(44),250
(2),248(4),239(6),237(1
5),224(4),222(5),212(3),2
10(6),199(3),197(6),163(1
7),130(8),128(21),95(10). 高分解能 MS (C1618ClNO2) 計算値:
291.1025, 実測値: 291.1013.
(C1618Cl*NO2) 計算値: 293.099
5, 実測値: 293.1014.
TLC R f 0.68 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.51 to 1.80 (m, 6H), 2.35 (dd, J
= 10.9, 7.0 Hz, 2H), 2.87 to 2.92
(M, 2H), 3.29 (s, 3H), 5.96 (t,
J = 3.0Hz, 1H), 6.14 (t, J = 3.0H
z, 1H), 6.69 (t, J = 7.0Hz, 1H),
6.78 (s, 1H), 7.56 (br, 1H). IR spectrum (neat) 3720-3300
(Br m), 2920 (m), 2850 (w), 16
25 (m), 1600 (m), 1560 (m), 144
5 (w), 1380 (m), 1100 (w), 1060
(M), 1015 (m) cm -1 . Low resolution MS m / e (relative ratio) 293 (M, 3
3), 291 (M, 100), 278 (4), 276.
(10), 265 (15), 263 (44), 250
(2), 248 (4), 239 (6), 237 (1
5), 224 (4), 222 (5), 212 (3), 2
10 (6), 199 (3), 197 (6), 163 (1
7), 130 (8), 128 (21), 95 (10). High resolution MS (C 16 H 18 ClNO 2 ) Calculated value:
291.125, measured value: 291.1013.
(C 16 H 18 Cl * NO 2) Calculated: 293.099
5, measured value: 293.1014.

【0118】実施例7Example 7

【0119】[0119]

【化36】 Embedded image

【0120】5−(3−クロロ−1−p−トルエンスル
ホニル−2−ピロリル)−3−メトキシフラン(11.
5mg,0.0327mmol)、シクロオクタノン
(82.6mg,0.654mmol)、炭酸カリウム
(22.6mg,0.164mmol)、およびメタノ
ール(0.3mL)の混合物を封管中、120℃で3日
間加熱した。反応混合物を減圧下に濃縮し、残渣をシリ
カゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3−
クロロ−2−ピロリル)−2−(1−シクロオクテニ
ル)−3−メトキシフラン(3.7mg,0.0121
mmol)を37%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (11.
5 mg, 0.0327 mmol), cyclooctanone (82.6 mg, 0.654 mmol), potassium carbonate (22.6 mg, 0.164 mmol), and methanol (0.3 mL) in a sealed tube at 120 ° C. Heated for days. The reaction mixture was concentrated under reduced pressure and the residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
Purify with 2: 1, 1% triethylamine) to give 5- (3-
Chloro-2-pyrrolyl) -2- (1-cyclooctenyl) -3-methoxyfuran (3.7 mg, 0.0121
mmol) was obtained in a yield of 37%.

【0121】TLC Rf 0.67(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.50〜1.67(m,6H),1.71〜1.85
(m,2H),2.28〜2.40(m,2H),2.
83(dd,J=6.4,6.0Hz,2H),3.2
9(s,3H),5.95(t,J=3.0Hz,1
H),6.15(dd,J=3.0,2.8Hz,1
H),6.49(t,J=8.5Hz,1H),6.7
7(s,1H),7.56(br,1H). IRスペクトル (neat) 3430(br
m),2920(s),2850(m),1625
(m),1570(m),1460(m),1380
(m),1235(w),1095(m),1025
(m)cm-1. 低分解能 MS m/e(相対比) 307(M,1
9),305(M,54),279(34),277
(100),264(11),262(22),239
(11),237(32),130(10),128
(27). 高分解能 MS (C1720ClNO2) 計算値:
305.1181, 実測値: 305.1162.
(C1720Cl*NO2) 計算値: 307.115
2, 実測値: 307.1170.
TLC R f 0.67 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.50 to 1.67 (m, 6H), 1.71 to 1.85
(M, 2H), 2.28 to 2.40 (m, 2H), 2.
83 (dd, J = 6.4, 6.0 Hz, 2H), 3.2
9 (s, 3H), 5.95 (t, J = 3.0Hz, 1
H), 6.15 (dd, J = 3.0, 2.8 Hz, 1
H), 6.49 (t, J = 8.5 Hz, 1H), 6.7.
7 (s, 1H), 7.56 (br, 1H). IR spectrum (neat) 3430 (br
m), 2920 (s), 2850 (m), 1625
(M), 1570 (m), 1460 (m), 1380
(M), 1235 (w), 1095 (m), 1025
(M) cm -1 . Low resolution MS m / e (relative ratio) 307 (M, 1
9), 305 (M, 54), 279 (34), 277.
(100), 264 (11), 262 (22), 239
(11), 237 (32), 130 (10), 128
(27). High resolution MS (C 17 H 20 ClNO 2 ) Calculated value:
305.1181, measured value: 305.1162.
(C 17 H 20 Cl * NO 2) Calculated: 307.115
2, measured value: 307.1170.

【0122】実施例8Embodiment 8

【0123】[0123]

【化37】 Embedded image

【0124】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(12.7mg,0.0361mmo
l)、2−アセチル−1−p−トルエンスルホニルピロ
ール(19.0mg,0.0722mmol)、及びオ
ルトギ酸トリメチル(0.050mL,0.46mmo
l)のメタノール(0.36mL)溶液にカンファース
ルホン酸(4.2mg,0.018mmol)を加え室
温で4時間かきまぜた。反応混合物をシリカゲル薄層ク
ロマトグラフィ(ヘキサン/酢酸エチル 2:1)で精
製して5−(3−クロロ−1−p−トルエンスルホニル
−2−ピロリル)−3−メトキシ−2−[1−(1−p
−トルエンスルホニル−2−ピロリル)エテニル]フラ
ン(7.1mg,0.0119mmol)を33%の収
率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in an argon stream.
Methoxyfuran (12.7mg, 0.0361mmo
1), 2-acetyl-1-p-toluenesulfonylpyrrole (19.0 mg, 0.0722 mmol), and trimethyl orthoformate (0.050 mL, 0.46 mmo).
Camphorsulfonic acid (4.2 mg, 0.018 mmol) was added to a solution of 1) in methanol (0.36 mL), and the mixture was stirred at room temperature for 4 hours. The reaction mixture was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1) to give 5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxy-2- [1- (1 -P
-Toluenesulfonyl-2-pyrrolyl) ethenyl] furan (7.1 mg, 0.0119 mmol) was obtained in 33% yield.

【0125】TLC Rf 0.37(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.77(s,3H),1.79(s,3H),3.1
0(s,3H),4.95(d,J=1.8Hz,1
H),5.87(d,J=1.8Hz,1H),5.9
5(d,J=3.5Hz,1H),6.07(dd,J
=3.4,3.2Hz,1H),6.18(dd,J=
3.2,1.8Hz,1H),6.34(s,1H),
6.65(d,J=8.0Hz,2H),6.83
(d,J=8.2Hz,2H),7.30(d,J=
3.5Hz,1H),7.47(dd,J=3.4,
1.8Hz,1H),7.70(d,J=8.4Hz,
2H),7.75(d,J=8.3Hz,2H). IRスペクトル (neat) 2970(w),29
40(m),2870(w),1740(w),146
5(w),1390(m),1075(m),810
(w)cm-1. 低分解能 MS m/e(相対比) 598(M,
2),596(M,5),531(3),441
(5),379(5),377(14),364
(2),362(4),286(9),245(3),
243(8),91(100). 高分解能 MS (C2925ClN262) 計算
値: 596.0840,実測値: 596.082
6. (C2925Cl*262) 計算値: 59
8.0811, 実測値: 598.0797.
TLC R f 0.37 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.77 (s, 3H), 1.79 (s, 3H), 3.1
0 (s, 3H), 4.95 (d, J = 1.8Hz, 1
H), 5.87 (d, J = 1.8Hz, 1H), 5.9
5 (d, J = 3.5 Hz, 1 H), 6.07 (dd, J
= 3.4, 3.2 Hz, 1H), 6.18 (dd, J =
3.2, 1.8 Hz, 1H), 6.34 (s, 1H),
6.65 (d, J = 8.0 Hz, 2H), 6.83
(D, J = 8.2 Hz, 2H), 7.30 (d, J =
3.5 Hz, 1 H), 7.47 (dd, J = 3.4,
1.8 Hz, 1 H), 7.70 (d, J = 8.4 Hz,
2H), 7.75 (d, J = 8.3 Hz, 2H). IR spectrum (neat) 2970 (w), 29
40 (m), 2870 (w), 1740 (w), 146
5 (w), 1390 (m), 1075 (m), 810
(W) cm -1 . Low resolution MS m / e (relative ratio) 598 (M,
2), 596 (M, 5), 531 (3), 441
(5), 379 (5), 377 (14), 364
(2), 362 (4), 286 (9), 245 (3),
243 (8), 91 (100). High resolution MS (C 29 H 25 ClN 2 O 6 S 2) Calculated: 596.0840, Found: 596.082
6. (C 29 H 25 Cl * N 2 O 6 S 2) Calculated: 59
8.0811, Found: 598.0797.

【0126】実施例9Example 9

【0127】[0127]

【化38】 Embedded image

【0128】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(17.9mg,0.0509mmo
l)、2−アセチル−1−tert−ブトキシカルボニ
ルピロール(21.3mg,0.102mmol)、及
びオルトギ酸トリメチル(0.050mL,0.46m
mol)のメタノール(0.5mL)溶液にカンファー
スルホン酸(2.4mg,0.010mmol)を加え
室温で4時間かきまぜた。反応混合物を減圧下濃縮し、
残渣をシリカゲル薄層クロマトグラフィ(ヘキサン/酢
酸エチル 2:1)で精製して2−[1−(1−ter
t−ブトキシカルボニル−2−ピロリル)エテニル]−
5−(3−クロロ−1−p−トルエンスルホニル−2−
ピロリル)−3−メトキシフラン(12.1mg,0.
0223mmol)を44%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in an argon stream.
Methoxyfuran (17.9 mg, 0.0509 mmo
l), 2-acetyl-1-tert-butoxycarbonylpyrrole (21.3 mg, 0.102 mmol), and trimethyl orthoformate (0.050 mL, 0.46 m).
camphorsulfonic acid (2.4 mg, 0.010 mmol) was added to a methanol (0.5 mL) solution of (mol) and stirred at room temperature for 4 hours. The reaction mixture was concentrated under reduced pressure,
The residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1) to give 2- [1- (1-ter
t-butoxycarbonyl-2-pyrrolyl) ethenyl]-
5- (3-chloro-1-p-toluenesulfonyl-2-
Pyrrolyl) -3-methoxyfuran (12.1 mg, 0.
0223 mmol) was obtained in a yield of 44%.

【0129】TLC Rf 0.73(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.31(s,9H),1.79(s,3H),3.1
5(s,3H),5.23(d,J=2.1Hz,1
H),5.73(d,J=2.1Hz,1H),5.9
6(d,J=3.5Hz,1H),6.12(t,J=
3.2Hz,1H),6.29(dd,J=3.2,
2.0Hz,1H),6.32(s,1H),6.67
(d,J=8.1Hz,2H),7.25(d,J=
3.5Hz,1H),7.50(d,J=8.4Hz,
2H),7.59(dd,J=7.2,2.0Hz,1
H). IRスペクトル (neat) 2940(w),17
40(s),1405(w),1380(m),134
5(m),1325(s),1260(w),1220
(w),1180(m),1155(m),1140
(m),1120(m),1090(w),1065
(w),1015(w)cm-1. 低分解能 MS m/e(相対比) 544(M,
5),542(M,12),487(27),486
(32),485(55),332(11),331
(17),330(18),289(17),287
(51),252(10),162(17),128
(11),91(37),57(100) 高分解能 MS (C2727ClN26S) 計算値:
542.1276,実測値: 542.1251.
(C2727Cl*26S) 計算値: 544.12
46, 実測値: 544.1238.
TLC R f 0.73 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.31 (s, 9H), 1.79 (s, 3H), 3.1
5 (s, 3H), 5.23 (d, J = 2.1Hz, 1
H), 5.73 (d, J = 2.1 Hz, 1H), 5.9
6 (d, J = 3.5 Hz, 1 H), 6.12 (t, J =
3.2 Hz, 1 H), 6.29 (dd, J = 3.2,
2.0 Hz, 1H), 6.32 (s, 1H), 6.67
(D, J = 8.1 Hz, 2H), 7.25 (d, J =
3.5 Hz, 1 H), 7.50 (d, J = 8.4 Hz,
2H), 7.59 (dd, J = 7.2, 2.0 Hz, 1
H). IR spectrum (neat) 2940 (w), 17
40 (s), 1405 (w), 1380 (m), 134
5 (m), 1325 (s), 1260 (w), 1220
(W), 1180 (m), 1155 (m), 1140
(M), 1120 (m), 1090 (w), 1065
(W), 1015 (w) cm -1 . Low resolution MS m / e (relative ratio) 544 (M,
5), 542 (M, 12), 487 (27), 486.
(32), 485 (55), 332 (11), 331
(17), 330 (18), 289 (17), 287
(51), 252 (10), 162 (17), 128
(11), 91 (37), 57 (100) High resolution MS (C 27 H 27 ClN 2 O 6 S) Calculated value:
542.1276, measured value: 542.1251.
(C 27 H 27 Cl * N 2 O 6 S) Calculated: 544.12
46, found: 544.1238.

【0130】実施例10Example 10

【0131】[0131]

【化39】 Embedded image

【0132】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシ−2−[1−(1−p−トルエンスルホニル−
2−ピロリル)エテニル]フラン(3.0mg,0.0
050mmol)のテトラヒドロフラン(0.1mL)
/メタノール(0.1mL)溶液にナトリウムメトキシ
ド(27mg,0.50mmol)を加え、室温で5時
間かきまぜた。反応混合物を減圧下濃縮し、残渣をシリ
カゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3−
クロロ−2−ピロリル)−3−メトキシ−2−[1−
(1−p−トルエンスルホニル−2−ピロリル)エテニ
ル]フラン(1.6mg,0.0036mmol)を7
2%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in a stream of argon.
Methoxy-2- [1- (1-p-toluenesulfonyl-
2-pyrrolyl) ethenyl] furan (3.0 mg, 0.0
050 mmol) of tetrahydrofuran (0.1 mL)
/ Methanol (0.1 mL) solution was added with sodium methoxide (27 mg, 0.50 mmol) and stirred at room temperature for 5 hours. The reaction mixture was concentrated under reduced pressure, and the residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
Purify with 2: 1, 1% triethylamine) to give 5- (3-
Chloro-2-pyrrolyl) -3-methoxy-2- [1-
7- (1-p-toluenesulfonyl-2-pyrrolyl) ethenyl] furan (1.6 mg, 0.0036 mmol)
Obtained in a yield of 2%.

【0133】TLC Rf 0.47(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.73(s,3H),3.23(s,3H),5.2
5(d,J=1.8Hz,1H),5.80(t,J=
3.0Hz,1H),6.05(t,J=3.0Hz,
1H),6.08(d,J=1.7HZ,1H),6.
10(t,J=3.3Hz,1H),6.24(dd,
J=3.2,1.8Hz,1H),6.54(d,J=
8.1Hz,2H),6.65(s,1H),7.50
(dd,J=3.4,1.8Hz,1H),7.62
(d,J=8.3Hz,2H). IRスペクトル (neat) 3500〜3200
(br w),2940(w),1660(w),16
30(m),1575(m),1550(m),146
5(w),1370(m),1250(w),1220
(w),1180(m),1155(m),1100
(w),1060(w),895(w),820(w)
cm-1. 低分解能 MS m/e(相対比) 444(M,2
5),442(M,60),379(12),377
(29),365(3),363(6),311(1
8),289(14),287(32),162(3
3),91(100). 高分解能 MS (C2219ClN24S) 計算値:
442.0773,実測値: 442.0763.
(C2219Cl*24S) 計算値: 444.07
23, 実測値: 444.0717.
TLC R f 0.47 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.73 (s, 3H), 3.23 (s, 3H), 5.2
5 (d, J = 1.8 Hz, 1H), 5.80 (t, J =
3.0 Hz, 1 H), 6.05 (t, J = 3.0 Hz,
1H), 6.08 (d, J = 1.7HZ, 1H), 6.
10 (t, J = 3.3 Hz, 1 H), 6.24 (dd,
J = 3.2, 1.8 Hz, 1H), 6.54 (d, J =
8.1Hz, 2H), 6.65 (s, 1H), 7.50
(Dd, J = 3.4, 1.8 Hz, 1H), 7.62
(D, J = 8.3 Hz, 2H). IR spectrum (neat) 3500-3200
(Br w), 2940 (w), 1660 (w), 16
30 (m), 1575 (m), 1550 (m), 146
5 (w), 1370 (m), 1250 (w), 1220
(W), 1180 (m), 1155 (m), 1100
(W), 1060 (w), 895 (w), 820 (w)
cm -1 . Low resolution MS m / e (relative ratio) 444 (M, 2
5), 442 (M, 60), 379 (12), 377
(29), 365 (3), 363 (6), 311 (1
8), 289 (14), 287 (32), 162 (3
3), 91 (100). High resolution MS (C 22 H 19 ClN 2 O 4 S) Calculated value:
442.0773, measured value: 442.0763.
(C 22 H 19 Cl * N 2 O 4 S) Calculated: 444.07
23, measured value: 444.0717.

【0134】実施例11Example 11

【0135】[0135]

【化40】 Embedded image

【0136】アルゴン気流中、室温で2−[1−(1−
tert−ブトキシカルボニル−2−ピロリル)エテニ
ル]−5−(3−クロロ−1−p−トルエンスルホニル
−2−ピロリル)−3−メトキシフラン(13.6m
g,0.0250mmol)をトリフルオロ酢酸(0.
1mL)に溶解し、室温で4時間かきまぜた。反応混合
物を飽和炭酸水素ナトリウム水中にあけ、エーテルで3
回抽出した。有機層を集め硫酸マグネシウムで乾燥した
後エバポレータで濃縮した。残渣をシリカゲル薄層クロ
マトグラフィ(ヘキサン/酢酸エチル 2:1,1%ト
リエチルアミン)で精製して5−(3−クロロ−1−p
−トルエンスルホニル−2−ピロリル)−3−メトキシ
−2−[1−(2−ピロリル)エテニル]フラン(8.
0mg,0.018mmol)を72%の収率で得た。
2- [1- (1-
tert-Butoxycarbonyl-2-pyrrolyl) ethenyl] -5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (13.6m
g, 0.0250 mmol) to trifluoroacetic acid (0.
1 mL) and stirred at room temperature for 4 hours. The reaction mixture is poured into saturated sodium hydrogencarbonate water and washed with ether.
Extracted times. The organic layers were collected, dried over magnesium sulfate, and then concentrated by an evaporator. The residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 5- (3-chloro-1-p.
-Toluenesulfonyl-2-pyrrolyl) -3-methoxy-2- [1- (2-pyrrolyl) ethenyl] furan (8.
0 mg, 0.018 mmol) was obtained with a yield of 72%.

【0137】TLC Rf 0.50(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.70(s,3H),3.21(s,3H),5.6
5(d,J=1.2Hz,1H),5.82(d,J=
1.2Hz,1H),5.94(d,J=3.5Hz,
1H),6.28〜6.32(m,1H),6.29
(s,1H),6.48(d,J=8.0Hz,2
H),6.50〜6.55(m,1H),6.71〜
6.75(m,1H),7.23(d,J=3.5H
z,1H),7.36(d,J=8.5Hz,2H),
9.09(br,1H). IRスペクトル (neat) 3430(m),31
60(w),2950(m),2870(w),164
0(w),1600(m),1530(w),1465
(w),1380(s),1300(w),1215
(w),1195(w),1180(vs),1140
(s),1095(w),1070(w),1020
(w),940(w),915(w),820(m)c
-1. 低分解能 MS m/e(相対比) 444(M,
6),442(M,10),353(5),351(1
2),289(10),287(22),139(2
2),124(24),91(100). 高分解能 MS (C2219ClN24S) 計算値:
442.0753,実測値: 442.0776.
(C2219Cl*24S) 計算値: 444.07
22, 実測値: 444.0693.
TLC R f 0.50 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.70 (s, 3H), 3.21 (s, 3H), 5.6
5 (d, J = 1.2 Hz, 1H), 5.82 (d, J =
1.2Hz, 1H), 5.94 (d, J = 3.5Hz,
1H), 6.28 to 6.32 (m, 1H), 6.29
(S, 1H), 6.48 (d, J = 8.0 Hz, 2
H), 6.50 to 6.55 (m, 1H), 6.71
6.75 (m, 1H), 7.23 (d, J = 3.5H
z, 1H), 7.36 (d, J = 8.5Hz, 2H),
9.09 (br, 1H). IR spectrum (neat) 3430 (m), 31
60 (w), 2950 (m), 2870 (w), 164
0 (w), 1600 (m), 1530 (w), 1465
(W), 1380 (s), 1300 (w), 1215
(W), 1195 (w), 1180 (vs), 1140
(S), 1095 (w), 1070 (w), 1020
(W), 940 (w), 915 (w), 820 (m) c
m -1 . Low resolution MS m / e (relative ratio) 444 (M,
6), 442 (M, 10), 353 (5), 351 (1
2), 289 (10), 287 (22), 139 (2
2), 124 (24), 91 (100). High resolution MS (C 22 H 19 ClN 2 O 4 S) Calculated value:
442.0753, measured value: 442.0776.
(C 22 H 19 Cl * N 2 O 4 S) Calculated: 444.07
22, measured value: 444.0693.

【0138】実施例12Example 12

【0139】[0139]

【化41】 Embedded image

【0140】アルゴン気流中、室温で2−[1−(1−
tert−ブトキシカルボニル−2−ピロリル)エテニ
ル]−5−(3−クロロ−1−p−トルエンスルホニル
−2−ピロリル)−3−メトキシフラン(14.3m
g,0.0263mmol)のメタノール(0.5m
L)溶液に炭酸カリウム(36.3mg,0.263m
mol)を加え、室温で17時間かきまぜた。反応混合
物を減圧下濃縮し、残渣をシリカゲル薄層クロマトグラ
フィ(ヘキサン/酢酸エチル 2:1,1%トリエチル
アミン)で精製して2−[1−(1−tert−ブトキ
シカルボニル−2−ピロリル)エテニル]−5−(3−
クロロ−2−ピロリル)−3−メトキシフラン(5.2
mg,0.0134mmol)を51%の収率で得た。
2- [1- (1-
tert-Butoxycarbonyl-2-pyrrolyl) ethenyl] -5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (14.3m
g, 0.0263 mmol) of methanol (0.5 m
L) solution into potassium carbonate (36.3 mg, 0.263 m)
mol) was added and the mixture was stirred at room temperature for 17 hours. The reaction mixture was concentrated under reduced pressure, and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 2- [1- (1-tert-butoxycarbonyl-2-pyrrolyl) ethenyl]. -5- (3-
Chloro-2-pyrrolyl) -3-methoxyfuran (5.2
mg, 0.0134 mmol) was obtained in a yield of 51%.

【0141】TLC Rf 0.67(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.17(s,9H),3.23(s,3H),5.4
1(d,J=2.0Hz,1H),5.86(t,J=
3.0Hz,1H),5.97(d,J=2.0Hz,
1H),6.06(t,J=2.9Hz,1H),6.
16(t,J=3.3Hz,1H),6.39(dd,
J=3.3,1.9Hz,1H),6.74(s,1
H),7.60(dd,J=3.3,1.8Hz,1
H),7.86(br,1H). IRスペクトル (neat) 3550〜3180
(br m),2940(m),2870(w),17
40(s),1640(m),1470(w),141
0(m),1380(w),1330(s),1155
(m),1125(m),1065(w),1025
(w),895(w)cm-1. 低分解能 MS m/e(相対比) 390(M,1
1),388(M,31),333(34),331
(79),289(4),287(10),273(1
8),271(19),92(18),57(10
0). 高分解能 MS (C2021ClN24) 計算値:
388.1187, 実測値: 388.1158.
(C2021Cl*24) 計算値: 390.115
9, 実測値: 390.1184.
TLC R f 0.67 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.17 (s, 9H), 3.23 (s, 3H), 5.4
1 (d, J = 2.0 Hz, 1H), 5.86 (t, J =
3.0 Hz, 1 H), 5.97 (d, J = 2.0 Hz,
1H), 6.06 (t, J = 2.9 Hz, 1H), 6.
16 (t, J = 3.3 Hz, 1H), 6.39 (dd,
J = 3.3, 1.9 Hz, 1H), 6.74 (s, 1
H), 7.60 (dd, J = 3.3, 1.8 Hz, 1
H), 7.86 (br, 1H). IR spectrum (neat) 3550-3180
(Br m), 2940 (m), 2870 (w), 17
40 (s), 1640 (m), 1470 (w), 141
0 (m), 1380 (w), 1330 (s), 1155
(M), 1125 (m), 1065 (w), 1025
(W), 895 (w) cm -1 . Low resolution MS m / e (relative ratio) 390 (M, 1
1), 388 (M, 31), 333 (34), 331
(79), 289 (4), 287 (10), 273 (1
8), 271 (19), 92 (18), 57 (10)
0). High resolution MS (C 20 H 21 ClN 2 O 4) Calculated:
388.1187, Found: 388.1158.
(C 20 H 21 Cl * N 2 O 4) Calculated: 390.115
9, measured value: 390.1184.

【0142】実施例13Example 13

【0143】[0143]

【化42】 Embedded image

【0144】アルゴン気流中、室温で2−[1−(1−
tert−ブトキシカルボニル−2−ピロリル)エテニ
ル]−5−(3−クロロ−2−ピロリル)−3−メトキ
シフラン(5.2mg,0.013mmol)の重クロ
ロホルム(0.40mL)溶液をNMRチューブに移
し、トリフルオロ酢酸(0.10mL)を加えた。13
時間後、NMRで原料の消失を確認したのち反応混合物
を減圧下濃縮し、5−(3−クロロ−2−ピロリル)−
3−メトキシ−2−[1−(2H−ピロール−2−イリ
デン)エチル]フランのトリフルオロ酢酸塩(4.4m
g,0.011mmol)を82%の収率で得た。
2- [1- (1-
A solution of tert-butoxycarbonyl-2-pyrrolyl) ethenyl] -5- (3-chloro-2-pyrrolyl) -3-methoxyfuran (5.2 mg, 0.013 mmol) in deuterated chloroform (0.40 mL) was placed in an NMR tube. Transferred and trifluoroacetic acid (0.10 mL) was added. Thirteen
After hours, after confirming disappearance of raw materials by NMR, the reaction mixture was concentrated under reduced pressure to give 5- (3-chloro-2-pyrrolyl)-
Trimethoxyacetic acid salt of 3-methoxy-2- [1- (2H-pyrrole-2-ylidene) ethyl] furan (4.4 m
g, 0.011 mmol) was obtained with a yield of 82%.

【0145】TLC Rf 0.30(クロロホルム/
メタノール 9:1,1%トリフルオロ酢酸). 融点 174〜176℃1 HNMRスペクトル (200MHz,CDCl3)δ
2.68(s,3H),4.22(s,3H),6.
43(br t,J=2.2Hz,1H),6.53
(quint,J=2.1Hz,1H),7.10
(s,1H),7.23〜7.28(m,1H),7.
49(br t,J=3.0Hz,1H),8.04〜
8.09(m,1H),12.40(br,1H),1
4.57(br,1H). IRスペクトル (neat) 3620〜3030
(br m),2930(w),1700(m),16
85(m),1590(s),1550(s),147
0(w),1430(m),1390(m),1370
(w),1300(m),1260(w),1235
(w),1210(s),1170(m),1130
(vs),1060(m),1010(w),930
(w),880(m),800(m),765(m),
730(m)cm-1. 低分解能 MS m/e(相対比) 290(M−CF
3CO2H,36),288(M−CF3CO2H,10
0),275(10),273(23),271(2
3),259(5),243(9),209(10),
182(10),144(10),125(28),9
2(76). 高分解能 MS (C1513ClN22,M−CF3
2H) 計算値: 288.0664, 実測値:
288.0656. (C1513Cl*22,M−C
3CO2H) 計算値: 290.0635, 実測
値: 290.0656. 元素分析 (C1714ClF324) 計算値:
C;50.70,H;3.50,N;6.96, 実測
値: C;50.56,H;3.44,N;6.74.
TLC R f 0.30 (chloroform /
Methanol 9: 1, 1% trifluoroacetic acid). Melting point 174 to 176 ° C. 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
2.68 (s, 3H), 4.22 (s, 3H), 6.
43 (brt, J = 2.2 Hz, 1H), 6.53
(Quint, J = 2.1 Hz, 1H), 7.10
(S, 1H), 7.23 to 7.28 (m, 1H), 7.
49 (brt, J = 3.0 Hz, 1H), 8.04 to
8.09 (m, 1H), 12.40 (br, 1H), 1
4.57 (br, 1H). IR spectrum (neat) 3620-3030
(Br m), 2930 (w), 1700 (m), 16
85 (m), 1590 (s), 1550 (s), 147
0 (w), 1430 (m), 1390 (m), 1370
(W), 1300 (m), 1260 (w), 1235
(W), 1210 (s), 1170 (m), 1130
(Vs), 1060 (m), 1010 (w), 930
(W), 880 (m), 800 (m), 765 (m),
730 (m) cm -1 . Low resolution MS m / e (relative ratio) 290 (M-CF
3 CO 2 H, 36), 288 (M-CF 3 CO 2 H, 10
0), 275 (10), 273 (23), 271 (2
3), 259 (5), 243 (9), 209 (10),
182 (10), 144 (10), 125 (28), 9
2 (76). High resolution MS (C 15 H 13 ClN 2 O 2, M-CF 3 C
O 2 H) Calculated: 288.0664, Found:
288.0656. (C 15 H 13 Cl * N 2 O 2, M-C
F 3 CO 2 H) Calculated value: 290.0635, Measured value: 290.0656. Elemental analysis (C 17 H 14 ClF 3 N 2 O 4) Calculated:
C; 50.70, H; 3.50, N; 6.96, found: C; 50.56, H; 3.44, N; 6.74.

【0146】実施例14Example 14

【0147】[0147]

【化43】 Embedded image

【0148】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(12.3mg,0.0350mmo
l)、7−オキソ−1−p−トルエンスルホニル−4,
5,6,7−テトラヒドロインドール[参考文献:J.
Org.Chem.48,3214(1983)](2
0.2mg,0.0698mmol)、及びオルトギ酸
トリメチル(0.10mL,0.92mmol)のメタ
ノール(0.35mL)溶液にカンファースルホン酸
(1.6mg,0.0068mmol)を加え室温で7
時間かきまぜた。反応混合物を減圧下濃縮し、残渣をシ
リカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3
−クロロ−1−p−トルエンスルホニル−2−ピロリ
ル)−3−メトキシ−2−(1−p−トルエンスルホニ
ル−4,5−ジヒドロインドール−7−イル)フラン
(1.55mg,0.00249mmol)を7%の収
率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in a stream of argon.
Methoxyfuran (12.3mg, 0.0350mmo
l), 7-oxo-1-p-toluenesulfonyl-4,
5,6,7-Tetrahydroindole [Reference: J.
Org. Chem. 48, 3214 (1983)] (2
0.2 mg, 0.0698 mmol) and trimethyl orthoformate (0.10 mL, 0.92 mmol) in methanol (0.35 mL) were added with camphorsulfonic acid (1.6 mg, 0.0068 mmol) at room temperature.
Stir the time. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 5- (3
-Chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxy-2- (1-p-toluenesulfonyl-4,5-dihydroindol-7-yl) furan (1.55 mg, 0.00249 mmol) Was obtained in a yield of 7%.

【0149】TLC Rf 0.45(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.72(s,3H),1.74(s,3H),1.7
8〜2.01(m,4H),3.52(s,3H),
5.84(d,J=3.3Hz,1H),5.98
(d,J=3.6Hz,1H),6.32(t,J=
5.1Hz,1H),6.59(d,J=8.2Hz,
2H),6.61(s,1H),6.70(d,J=
8.1Hz,2H),7.20(d,J=3.3Hz,
1H),7.31(d,J=3.5Hz,1H),7.
62(d,J=8.3Hz,2H),7.71(d,J
=8.4Hz,2H). IRスペクトル (neat) 2930(m),28
60(w),1740(w),1730(w),160
0(w),1480(w),1380(m),1180
(s),1135(m),815(m)cm-1. 低分解能 MS m/e(相対比) 624(M,1
5),622(M,30),469(18),467
(43),314(8),313(14),312(2
0),144(26),91(100). 高分解能 MS (C3127ClN262) 計算
値: 622.0996,実測値: 622.097
2.
TLC R f 0.45 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.72 (s, 3H), 1.74 (s, 3H), 1.7
8 to 2.01 (m, 4H), 3.52 (s, 3H),
5.84 (d, J = 3.3 Hz, 1H), 5.98
(D, J = 3.6 Hz, 1 H), 6.32 (t, J =
5.1 Hz, 1 H), 6.59 (d, J = 8.2 Hz,
2H), 6.61 (s, 1H), 6.70 (d, J =
8.1Hz, 2H), 7.20 (d, J = 3.3Hz,
1H), 7.31 (d, J = 3.5Hz, 1H), 7.
62 (d, J = 8.3 Hz, 2H), 7.71 (d, J
= 8.4 Hz, 2H). IR spectrum (neat) 2930 (m), 28
60 (w), 1740 (w), 1730 (w), 160
0 (w), 1480 (w), 1380 (m), 1180
(S), 1135 (m), 815 (m) cm -1 . Low resolution MS m / e (relative ratio) 624 (M, 1
5), 622 (M, 30), 469 (18), 467
(43), 314 (8), 313 (14), 312 (2
0), 144 (26), 91 (100). High resolution MS (C 31 H 27 ClN 2 O 6 S 2 ) Calculated value: 622.0996, Found value: 622.097
2.

【0150】実施例15Example 15

【0151】[0151]

【化44】 Embedded image

【0152】アルゴン気流中、室温で5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(15.6mg,0.0443mmo
l)、1−tert−ブトキシカルボニル−7−オキソ
−4,5,6,7−テトラヒドロインドール[参考文
献:J.Org.Chem.48,3214(198
3)](20.9mg,0.0833mmol)、及び
オルトギ酸トリメチル(0.050mL,0.46mm
ol)のメタノール(0.35mL)溶液にカンファー
スルホン酸(2.1mg,0.0090mmol)を加
え室温で2時間かきまぜた。反応混合物を減圧下濃縮
し、残渣をシリカゲル薄層クロマトグラフィ(ヘキサン
/酢酸エチル 2:1,1%トリエチルアミン)で精製
して2−(1−tert−ブトキシカルボニル−4,5
−ジヒドロインドール−7−イル)−5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(6.4mg,0.011mmol)を
25%の収率で得た。
5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3- at room temperature in an argon stream.
Methoxyfuran (15.6mg, 0.0443mmo
l), 1-tert-butoxycarbonyl-7-oxo-4,5,6,7-tetrahydroindole [Reference: J. Org. Chem. 48, 3214 (198
3)] (20.9 mg, 0.0833 mmol), and trimethyl orthoformate (0.050 mL, 0.46 mm)
ol) in methanol (0.35 mL) was added camphorsulfonic acid (2.1 mg, 0.0090 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine), and 2- (1-tert-butoxycarbonyl-4,5).
-Dihydroindol-7-yl) -5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-
Methoxyfuran (6.4 mg, 0.011 mmol) was obtained in 25% yield.

【0153】TLC Rf 0.70(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.26(s,9H),1.78(s,3H),2.0
5〜2.17(m,2H),2.28〜2.36(m,
2H),3.26(s,3H),6.01(d,J=
3.5Hz,1H),6.04(d,J=3.2Hz,
1H),6.33(t,J=5.4Hz,1H),6.
44(s,1H),6.65(d,J=8.2Hz,2
H),7.32(d,J=3.6Hz,1H),7.3
5(d,J=3.2Hz,1H),7.56(d,J=
8.4Hz,2H). IRスペクトル (neat) 2940(m),17
45(s),1730(w),1715(w),163
5(w),1600(w),1565(w),1470
(w),1375(vs),1335(m),1310
(m),1260(m),1215(w),1180
(s),1160(s),1140(m),1100
(w),1070(w),1030(m),910
(w),850(w),820(m)cm-1. 低分解能 MS m/e(相対比) 570(M,1
2),568(M,30),470(13),468
(35),315(34),313(99),144
(33),91(48),57(100). 高分解能 MS (C2929ClN26S) 計算値:
568.1432,実測値: 568.1423.
(C2929Cl*26S) 計算値: 570.14
03, 実測値: 570.1402.
TLC R f 0.70 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.26 (s, 9H), 1.78 (s, 3H), 2.0
5 to 2.17 (m, 2H), 2.28 to 2.36 (m,
2H), 3.26 (s, 3H), 6.01 (d, J =
3.5 Hz, 1 H), 6.04 (d, J = 3.2 Hz,
1H), 6.33 (t, J = 5.4Hz, 1H), 6.
44 (s, 1H), 6.65 (d, J = 8.2Hz, 2
H), 7.32 (d, J = 3.6Hz, 1H), 7.3
5 (d, J = 3.2 Hz, 1H), 7.56 (d, J =
8.4 Hz, 2H). IR spectrum (neat) 2940 (m), 17
45 (s), 1730 (w), 1715 (w), 163
5 (w), 1600 (w), 1565 (w), 1470
(W), 1375 (vs), 1335 (m), 1310
(M), 1260 (m), 1215 (w), 1180
(S), 1160 (s), 1140 (m), 1100
(W), 1070 (w), 1030 (m), 910
(W), 850 (w), 820 (m) cm -1 . Low resolution MS m / e (relative ratio) 570 (M, 1
2), 568 (M, 30), 470 (13), 468
(35), 315 (34), 313 (99), 144
(33), 91 (48), 57 (100). High resolution MS (C 29 H 29 ClN 2 O 6 S) calculated:
568.1432, Found: 568.1423.
(C 29 H 29 Cl * N 2 O 6 S) Calculated: 570.14
03, measured value: 570.1402.

【0154】実施例16Example 16

【0155】[0155]

【化45】 Embedded image

【0156】アルゴン気流中、室温で2−(1−ter
t−ブトキシカルボニル−4,5−ジヒドロインドール
−7−イル)−5−(3−クロロ−1−p−トルエンス
ルホニル−2−ピロリル)−3−メトキシフラン(2.
6mg,0.0046mmol)をトリフルオロ酢酸
(0.1mL)に溶解し、室温で3.5時間かきまぜ
た。反応混合物を飽和炭酸水素ナトリウム水中にあけ、
エーテルで3回抽出した。有機層を集め硫酸マグネシウ
ムで乾燥した後エバポレータで濃縮した。残渣をシリカ
ゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1)で精製して5−(3−クロロ−1−p−トルエ
ンスルホニル−2−ピロリル)−2−(4,5−ジヒド
ロインドール−7−イル)−3−メトキシフラン(1.
6mg,0.0034mmol)を74%の収率で得
た。
2- (1-ter) at room temperature in an argon stream.
t-Butoxycarbonyl-4,5-dihydroindol-7-yl) -5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (2.
6 mg, 0.0046 mmol) was dissolved in trifluoroacetic acid (0.1 mL) and stirred at room temperature for 3.5 hours. Pour the reaction mixture into saturated sodium hydrogen carbonate water,
Extracted three times with ether. The organic layers were collected, dried over magnesium sulfate, and then concentrated by an evaporator. The residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
2: 1) and 5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -2- (4,5-dihydroindol-7-yl) -3-methoxyfuran (1.
6 mg, 0.0034 mmol) was obtained with a yield of 74%.

【0157】TLC Rf 0.55(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
2.42〜2.51(m,2H),2.74(t,J=
8.3Hz,2H),3.20(s,3H),5.96
(d,J=3.5Hz,1H),6.22(t,J=
2.5Hz,1H),6.27(s,1H),6.44
(d,J=8.4Hz,2H),6.48(t,J=
5.3Hz,1H),6.54(t,J=2.6Hz,
1H),7.31(d,J=3.4Hz,1H),7.
32(d,J=8.5Hz,2H). IRスペクトル (neat) 3680〜3100
(br m),2940(m),2860(w),15
65(m),1465(w),1380(s),130
0(m),1180(s),1140(s),1095
(w),1070(w),1030(w),900
(w),820(m)cm-1. 低分解能 MS m/e(相対比) 470(M,2
0),468(M,54),466(15),315
(26),314(32),313(79),311
(36),144(50),91(100).
TLC R f 0.55 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
2.42 to 2.51 (m, 2H), 2.74 (t, J =
8.3 Hz, 2H), 3.20 (s, 3H), 5.96
(D, J = 3.5 Hz, 1 H), 6.22 (t, J =
2.5Hz, 1H), 6.27 (s, 1H), 6.44
(D, J = 8.4 Hz, 2H), 6.48 (t, J =
5.3 Hz, 1 H), 6.54 (t, J = 2.6 Hz,
1H), 7.31 (d, J = 3.4Hz, 1H), 7.
32 (d, J = 8.5 Hz, 2H). IR spectrum (neat) 3680-3100
(Br m), 2940 (m), 2860 (w), 15
65 (m), 1465 (w), 1380 (s), 130
0 (m), 1180 (s), 1140 (s), 1095
(W), 1070 (w), 1030 (w), 900
(W), 820 (m) cm -1 . Low resolution MS m / e (relative ratio) 470 (M, 2
0), 468 (M, 54), 466 (15), 315
(26), 314 (32), 313 (79), 311
(36), 144 (50), 91 (100).

【0158】実施例17Example 17

【0159】[0159]

【化46】 Embedded image

【0160】アルゴン気流中、室温で2−(1−ter
t−ブトキシカルボニル−4,5−ジヒドロインドール
−7−イル)−5−(3−クロロ−1−p−トルエンス
ルホニル−2−ピロリル)−3−メトキシフラン(2.
3mg,0.0040mmol)のメタノール(0.1
mL)溶液に炭酸カリウム(11.2mg,0.081
mmol)を加え、室温で5時間かきまぜた。反応混合
物を減圧下濃縮し、残渣をシリカゲル薄層クロマトグラ
フィ(ヘキサン/酢酸エチル 2:1,1%トリエチル
アミン)で精製して2−(1−tert−ブトキシカル
ボニル−4,5−ジヒドロインドール−7−イル)−5
−(3−クロロ−2−ピロリル)−3−メトキシフラン
(0.75mg,0.0018mmol)を45%の収
率で得た。
2- (1-ter) at room temperature in an argon stream.
t-Butoxycarbonyl-4,5-dihydroindol-7-yl) -5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxyfuran (2.
3 mg, 0.0040 mmol) of methanol (0.1
mL) solution to potassium carbonate (11.2 mg, 0.081
mmol) was added and the mixture was stirred at room temperature for 5 hours. The reaction mixture was concentrated under reduced pressure, the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine), and 2- (1-tert-butoxycarbonyl-4,5-dihydroindole-7-). Ill) -5
-(3-Chloro-2-pyrrolyl) -3-methoxyfuran (0.75 mg, 0.0018 mmol) was obtained with a yield of 45%.

【0161】TLC Rf 0.70(ヘキサン/酢酸
エチル 2:1).1 HNMRスペクトル (200MHz,C66)δ
1.12(s,9H),2.12〜2.43(m,4
H),3.38(s,3H),5.97(t,J=3.
0Hz,1H),6.09(d,J=3.2Hz,1
H),6.10(t,J=3.0Hz,1H),6.5
6(t,J=5.4Hz,1H),6.87(s,1
H),7.38(d,J=3.1Hz,1H),8.1
6(br,1H). IRスペクトル (neat) 3100(m),29
30(m),2860(w),1740(w),172
5(w),1675(vs),1630(m),156
5(m),1530(w),1465(m),1375
(s),1345(m),1260(m),1160
(s),1035(m),1020(m),890
(w)cm-1. 低分解能 MS m/e(相対比) 416(M,
9),414(M,25),358(6),316(1
5),314(44),301(5),299(1
4),57(100). 高分解能 MS (C2223ClN24) 計算値:
414.1345, 実測値: 414.1348.
TLC R f 0.70 (hexane / ethyl acetate 2: 1). 1 H NMR spectrum (200 MHz, C 6 D 6 ) δ
1.12 (s, 9H), 2.12 to 2.43 (m, 4
H), 3.38 (s, 3H), 5.97 (t, J = 3.
0Hz, 1H), 6.09 (d, J = 3.2Hz, 1
H), 6.10 (t, J = 3.0 Hz, 1H), 6.5
6 (t, J = 5.4 Hz, 1H), 6.87 (s, 1
H), 7.38 (d, J = 3.1 Hz, 1H), 8.1
6 (br, 1H). IR spectrum (neat) 3100 (m), 29
30 (m), 2860 (w), 1740 (w), 172
5 (w), 1675 (vs), 1630 (m), 156
5 (m), 1530 (w), 1465 (m), 1375
(S), 1345 (m), 1260 (m), 1160
(S), 1035 (m), 1020 (m), 890
(W) cm -1 . Low resolution MS m / e (relative ratio) 416 (M,
9), 414 (M, 25), 358 (6), 316 (1
5), 314 (44), 301 (5), 299 (1
4), 57 (100). High resolution MS (C 22 H 23 ClN 2 O 4) Calculated:
414.1345, Found: 414.1348.

【0162】実施例18Example 18

【0163】[0163]

【化47】 Embedded image

【0164】アルゴン気流中、室温で2−(1−ter
t−ブトキシカルボニル−4,5−ジヒドロインドール
−7−イル)−5−(3−クロロ−2−ピロリル)−3
−メトキシフラン(6.3mg,0.015mmol)
の重クロロホルム(0.40mL)溶液をNMRチュー
ブに移し、トリフルオロ酢酸(0.050mL)を加え
た。23時間後、NMRで原料の消失を確認したのち反
応混合物を減圧下濃縮し、5−(3−クロロ−2−ピロ
リル)−2−(5,6−ジヒドロ−4H−インドール−
7−イル)−3−メトキシフランのトリフルオロ酢酸塩
(0.83mg,0.0019mmol)を13%の収
率で得た。
2- (1-ter) at room temperature in an argon stream.
t-Butoxycarbonyl-4,5-dihydroindol-7-yl) -5- (3-chloro-2-pyrrolyl) -3
-Methoxyfuran (6.3 mg, 0.015 mmol)
The deuterochloroform (0.40 mL) solution was transferred to an NMR tube, and trifluoroacetic acid (0.050 mL) was added. After 23 hours, the disappearance of the starting materials was confirmed by NMR, and the reaction mixture was concentrated under reduced pressure to give 5- (3-chloro-2-pyrrolyl) -2- (5,6-dihydro-4H-indole-
The trifluoroacetic acid salt of 7-yl) -3-methoxyfuran (0.83 mg, 0.0019 mmol) was obtained in a yield of 13%.

【0165】TLC Rf 0.25(クロロホルム/
メタノール 9:1,1%トリフルオロ酢酸).1 HNMRスペクトル (200MHz,CDCl3)δ
2.04(quint,J=6.3Hz,2H),
2.85(t,J=6.3Hz,2H),3.13
(t,J=6.1Hz,2H),4.19(s,3
H),6.33(br s,1H),6.40(t,J
=2.4Hz,1H),7.06(s,1H),7.3
8〜7.42(m,1H),8.15〜8.18(m,
1H),12.79(br,1H),14.30(b
r,1H). IRスペクトル (neat) 3600〜3050
(br m),2940(m),2870(w),16
90(m),1565(w),1550(m),153
0(w),1515(w),1465(m),1430
(w),1390(w),1370(w),1300
(w),1265(w),1210(w),1180
(w),1130(m),1075(w),1030
(w),1000(w),890(w)cm-1. 低分解能 MS m/e(相対比) 316(M−CF
3CO2H,37),314(M−CF3CO2H,10
0),312(50),301(7),299(2
0),297(14),144(75). 高分解能 MS (C1715ClN22,M−CF3
2H) 計算値: 314.0820, 実測値:
314.0817. (C1715Cl*22,M−C
3CO2H) 計算値: 316.0791, 実測
値: 316.0825.
TLC R f 0.25 (chloroform /
Methanol 9: 1, 1% trifluoroacetic acid). 1 H NMR spectrum (200 MHz, CDCl 3 ) δ
2.04 (quint, J = 6.3 Hz, 2H),
2.85 (t, J = 6.3 Hz, 2H), 3.13
(T, J = 6.1 Hz, 2H), 4.19 (s, 3
H), 6.33 (br s, 1H), 6.40 (t, J
= 2.4 Hz, 1H), 7.06 (s, 1H), 7.3
8 to 7.42 (m, 1H), 8.15 to 8.18 (m,
1H), 12.79 (br, 1H), 14.30 (b
r, 1H). IR spectrum (neat) 3600 to 3050
(Br m), 2940 (m), 2870 (w), 16
90 (m), 1565 (w), 1550 (m), 153
0 (w), 1515 (w), 1465 (m), 1430
(W), 1390 (w), 1370 (w), 1300
(W), 1265 (w), 1210 (w), 1180
(W), 1130 (m), 1075 (w), 1030
(W), 1000 (w), 890 (w) cm −1 . Low resolution MS m / e (relative ratio) 316 (M-CF
3 CO 2 H, 37), 314 (M-CF 3 CO 2 H, 10
0), 312 (50), 301 (7), 299 (2
0), 297 (14), 144 (75). High resolution MS (C 17 H 15 ClN 2 O 2 , M-CF 3 C
O 2 H) Calculated: 314.0820, Found:
314.0817. (C 17 H 15 Cl * N 2 O 2, M-C
F 3 CO 2 H) Calculated: 316.0791, Found: 316.0825.

【0166】試験例 (悪性腫瘍細胞増殖抑制試験) マウスリンパ性白血病細胞(P388)を2−ヒドロキ
シエチルジスルフィド5μM、硫酸カナマイシン100
μg/mLを添加した10%牛胎児血清含有のRPMI
−1640培地に加え、培養細胞を1x104個/mL
に調整した。これに本発明の化合物である一般式[I]
および[II]で表される2−置換−3−アルコキシ−
5−(ピロール−2−イル)フラン誘導体を所定の濃度
になるように添加し、CO2培養器(CO25%,湿度1
00%,37℃)で4日間培養した。MTT比色法によ
り生存細胞数を計測して、対照群に対する増殖阻害率か
ら50%細胞増殖阻害濃度(IC50)を求めた。結果を
表1および表2に示す。
Test Example (Malignant Tumor Cell Growth Inhibition Test) Mouse lymphocytic leukemia cells (P388) were treated with 2-hydroxyethyl disulfide 5 μM and kanamycin sulfate 100.
RPMI containing 10% fetal bovine serum supplemented with μg / mL
Add 1 × 10 4 cells / mL to -1640 medium
Adjusted to. In addition, the compound of the general formula [I]
And 2-substituted-3-alkoxy-represented by [II]
A 5- (pyrrol-2-yl) furan derivative was added to a predetermined concentration, and a CO 2 incubator (CO 2 5%, humidity 1) was added.
The cells were cultured at 00%, 37 ° C for 4 days. The number of surviving cells was counted by the MTT colorimetric method, and the 50% cell growth inhibitory concentration (IC 50 ) was determined from the growth inhibition rate with respect to the control group. The results are shown in Tables 1 and 2.

【0167】表1.マウスリンパ性白血病細胞(P38
8)に対する50%増殖阻害濃度
Table 1. Mouse lymphocytic leukemia cell (P38
50% growth inhibitory concentration against

【0168】[0168]

【表1】 [Table 1]

【0169】表2.マウスリンパ性白血病細胞(P38
8)に対する50%増殖阻害濃度
Table 2. Mouse lymphocytic leukemia cell (P38
50% growth inhibitory concentration against

【0170】[0170]

【表2】 [Table 2]

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成8年5月24日[Submission date] May 24, 1996

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0028[Correction target item name] 0028

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0028】[0028]

【化21】 [Chemical 21]

【手続補正2】[Procedure amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0031[Correction target item name] 0031

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0031】第1工程 本工程は、一般式[III]で表される−アルコキシ
−(ピロール−2−イル)フラン誘導体(参考例参
照)のアミノ基の保護基であるスルホニル基を除去し、
生成した一般式[IV]で表される−アルコキシ−
−(ピロール−2−イル)フラン誘導体(参考例参照)
を単離することなく一般式[V]で表されるアルデヒド
と反応させ、本発明の化合物である一般式[Ia]で表
される2−置換−3−アルコキシ−5−(ピロール−2
−イル)フラン誘導体を製造するものである。
[0031] 4 first step This step is represented by the general formula [III] - alkoxy - 2 - (pyrrol-2-yl) furan derivatives sulfonyl group which is a protecting group of the amino groups of (reference example see) Removed,
The resulting 4 -alkoxy- 2 represented by the general formula [IV]
-(Pyrrol-2-yl) furan derivative (see Reference Example)
Is reacted with an aldehyde represented by the general formula [V] without isolation to give a 2-substituted-3-alkoxy-5- (pyrrole-2 represented by the general formula [Ia] which is a compound of the present invention.
-Yl) to produce a furan derivative.

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0043[Correction target item name] 0043

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0043】第5工程 本工程は、一般式[III]で表される−アルコキシ
−(ピロール−2−イル)フラン誘導体のアミノ基
の保護基であるスルホニル基を除去し、生成した一般式
[IV]で表される−アルコキシ−−(ピロール−
2−イル)フラン誘導体を単離することなく一般式[V
II]で表されるケトンと縮合させ、本発明の化合物で
ある一般式[Ie]で表される2−置換−3−アルコキ
シ−5−(ピロール−2−イル)フラン誘導体を製造す
るものである。
[0043] Fifth Step This formula 4 is represented by [III] - alkoxy - 2 - (pyrrol-2-yl) sulfonyl group is a protective group of the amino group of furan derivatives was removed to yield 4 -alkoxy- 2- (pyrrole-represented by the general formula [IV]
The 2-yl) furan derivative can be isolated by the general formula [V
II] is condensed with a ketone represented by the formula [II] to produce a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative represented by the general formula [Ie] of the present invention. is there.

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0045[Name of item to be corrected] 0045

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0045】第6工程 本工程は、一般式[III]で表される−アルコキシ
−(ピロール−2−イル)フラン誘導体と一般式
[VIII]で表される2−アセチルピロール誘導体を
オルトギ酸トリメチルと酸の存在下に縮合させ、本発明
の化合物である一般式[If]で表される2−置換−3
−アルコキシ−5−(ピロール−2−イル)フラン誘導
体を製造するものである。
[0045] Sixth Step This 4 represented by the general formula [III] - alkoxy - 2 - (pyrrol-2-yl) 2-acetyl pyrrole derivative represented by furan derivatives of the general formula [VIII] The 2-substituted-3 represented by the general formula [If], which is a compound of the present invention, is condensed with trimethyl orthoformate in the presence of an acid.
-Alkoxy-5- (pyrrol-2-yl) furan derivative.

【手続補正5】[Procedure Amendment 5]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0054[Correction target item name] 0054

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0054】第10工程 本工程は、一般式[III]で表される−アルコキシ
−(ピロール−2−イル)フラン誘導体と一般式
[IX]で表されるテトラヒドロインドール誘導体をオ
ルトギ酸トリメチルと酸の存在下に縮合させ、本発明の
化合物である一般式[Ii]で表される2−置換−3−
アルコキシ−5−(ピロール−2−イル)フラン誘導体
を製造するものである。
[0054] Tenth Step This formula 4 is represented by [III] - alkoxy - 2 - (pyrrol-2-yl) furan derivative with the general formula orthoformate tetrahydroindole derivative represented by [IX] 2-Substitution-3-3 represented by the general formula [Ii], which is a compound of the present invention, by condensation with trimethyl in the presence of an acid.
It is intended to produce an alkoxy-5- (pyrrol-2-yl) furan derivative.

【手続補正6】[Procedure correction 6]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0088[Correction target item name] 0088

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0088】アルゴン気流中、室温で3−クロロ−2−
[1,3−ジオキソ−4−(テトラヒドロ−2−ピラニ
ルオキシ)ブチル]−1−p−トルエンスルホニルピロ
−ル(93.9mg,0.213mmol)のメタノ−
ル(2.1mL)溶液にカンファースルホン酸(9.9
mg,0.043mmol)を加え室温で13時間かき
まぜた。反応混合物を飽和炭酸水素ナトリウム水中にあ
けエ−テルで3回抽出した。有機層を集め硫酸マグネシ
ウムで乾燥したのちエバポレ−タで濃縮した。残渣をシ
リカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して−(3
−クロロ−1−p−トルエンスルホニル−2−ピロリ
ル)−−メトキシフラン(56.7mg,0.161
mmol)を76%の収率で得た。
3-chloro-2- at room temperature in an argon stream.
Methanol of [1,3-dioxo-4- (tetrahydro-2-pyranyloxy) butyl] -1-p-toluenesulfonylpyrrole (93.9 mg, 0.213 mmol)
Solution (2.1 mL) with camphorsulfonic acid (9.9
(mg, 0.043 mmol) was added and the mixture was stirred at room temperature for 13 hours. The reaction mixture was poured into saturated sodium hydrogen carbonate water and extracted with ether three times. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 2- (3
- chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 - methoxy furan (56.7 mg, 0.161
mmol) was obtained in a yield of 76%.

【手続補正7】[Procedure amendment 7]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0092[Correction target item name] 0092

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0092】アルゴン気流中、室温で−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−
メトキシフラン(26.9mg,0.0765mmo
l)のメタノ−ル(0.8mL)溶液に炭酸カリウム
(106mg,0.767mmol)を加え室温で23
時間かきまぜた。反応混合物を飽和食塩水中にあけエー
テルで3回抽出した。有機層を集め硫酸マグネシウムで
乾燥したのちエバポレ−タで濃縮した。残渣をシリカゲ
ル薄層クロマトグラフィ(ヘキサン/酢酸エチル2:
1,1%トリエチルアミン)で精製して−(3−クロ
ロ−2−ピロリル)−−メトキシフラン(10.8m
g,0.0547mmol)を71%の収率で得た。
[0092] In an argon gas stream at room temperature for 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 -
Methoxyfuran (26.9 mg, 0.0765 mmo
To a solution of 1) in methanol (0.8 mL) was added potassium carbonate (106 mg, 0.767 mmol), and the mixture was stirred at room temperature for 23 hours.
Stir the time. The reaction mixture was poured into saturated saline and extracted 3 times with ether. The organic layers were collected, dried over magnesium sulfate, and then concentrated with an evaporator. The residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate 2:
Purification by 1,1% triethylamine) 2 - (3-chloro-2-pyrrolyl) - 4 - methoxy furan (10.8 m
g, 0.0547 mmol) was obtained in a yield of 71%.

【手続補正8】[Procedure amendment 8]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0096[Correction target item name] 0096

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0096】アルゴン気流中、室温で−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−
メトキシフラン(17.8mg,0.0506mmo
l)のメタノ−ル(0.5mL)溶液に炭酸カリウム
(35.0mg,0.253mmol)を加え室温で1
7時間かきまぜた。TLCで−(3−クロロ−2−ピ
ロリル)−−メトキシフランの生成を確認した後、シ
クロヘキサンカルボキシアルデヒド(30.6μL,
0.253mmol)を加え室温でさらに11時間かき
まぜた。反応混合物を減圧下に濃縮し、残渣をシリカゲ
ル薄層クロマトグラフィ(ヘキサン/酢酸エチル 2:
1,1%トリエチルアミン)で精製して5−(3−クロ
ロ−2−ピロリル)−2−(シクロヘキシルヒドロキシ
メチル)−3−メトキシフラン(8.1mg,0.02
6mmol)を52%の収率で得た。
[0096] In an argon gas stream at room temperature for 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 -
Methoxyfuran (17.8mg, 0.0506mmo
potassium carbonate (35.0 mg, 0.253 mmol) was added to a methanol (0.5 mL) solution of 1) at room temperature.
Stir for 7 hours. (3-chloro-2-pyrrolyl) - - 2 TLC 4 - After confirming the formation of methoxy furan, cyclohexane carboxaldehyde (30.6MyuL,
0.253 mmol) was added and the mixture was stirred at room temperature for 11 hours. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2:
Purification with 1,1% triethylamine) and 5- (3-chloro-2-pyrrolyl) -2- (cyclohexylhydroxymethyl) -3-methoxyfuran (8.1 mg, 0.02
6 mmol) was obtained with a yield of 52%.

【手続補正9】[Procedure amendment 9]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0112[Correction target item name] 0112

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0112】−(3−クロロ−1−p−トルエンスル
ホニル−2−ピロリル)−−メトキシフラン(14.
2mg,0.0404mmol)、シクロヘキサノン
(0.084mL,0.81mmol)、炭酸カリウム
(27.9mg,0.20mmol)、およびメタノー
ル(0.4mL)の混合物を封管中、100℃で17時
間加熱した。反応混合物を減圧下に濃縮し、残渣をシリ
カゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3−
クロロ−2−ピロリル)−2−(1−シクロヘキセニ
ル)−3−メトキシフラン(3.8mg,0.0136
mmol)を34%の収率で得た。
[0112] 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 - methoxy furan (14.
2 mg, 0.0404 mmol), cyclohexanone (0.084 mL, 0.81 mmol), potassium carbonate (27.9 mg, 0.20 mmol), and methanol (0.4 mL) in a sealed tube at 100 ° C. for 17 hours. did. The reaction mixture was concentrated under reduced pressure and the residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
Purify with 2: 1, 1% triethylamine) to give 5- (3-
Chloro-2-pyrrolyl) -2- (1-cyclohexenyl) -3-methoxyfuran (3.8 mg, 0.0136
mmol) was obtained in a yield of 34%.

【手続補正10】[Procedure amendment 10]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0116[Correction target item name]

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0116】−(3−クロロ−1−p−トルエンスル
ホニル−2−ピロリル)−−メトキシフラン(12.
5mg,0.0355mmol)、シクロヘプタノン
(0.084mL,0.71mmol)、炭酸カリウム
(24.6mg,0.178mmol)、およびメタノ
ール(0.4mL)の混合物を封管中、100℃で24
時間加熱した。反応混合物を減圧下に濃縮し、残渣をシ
リカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3
−クロロ−2−ピロリル)−2−(1−シクロヘプテニ
ル)−3−メトキシフラン(6.4mg,0.022m
mol)を62%の収率で得た。
[0116] 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 - methoxy furan (12.
5 mg, 0.0355 mmol), cycloheptanone (0.084 mL, 0.71 mmol), potassium carbonate (24.6 mg, 0.178 mmol), and methanol (0.4 mL) in a sealed tube at 100 ° C.
Heated for hours. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 5- (3
-Chloro-2-pyrrolyl) -2- (1-cycloheptenyl) -3-methoxyfuran (6.4 mg, 0.022 m
mol) was obtained in a yield of 62%.

【手続補正11】[Procedure amendment 11]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0120[Correction target item name]

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0120】−(3−クロロ−1−p−トルエンスル
ホニル−2−ピロリル)−−メトキシフラン(11.
5mg,0.0327mmol)、シクロオクタノン
(82.6mg,0.654mmol)、炭酸カリウム
(22.6mg,0.164mmol)、およびメタノ
ール(0.3mL)の混合物を封管中、120℃で3日
間加熱した。反応混合物を減圧下に濃縮し、残渣をシリ
カゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3−
クロロ−2−ピロリル)−2−(1−シクロオクテニ
ル)−3−メトキシフラン(3.7mg,0.0121
mmol)を37%の収率で得た。
[0120] 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 - methoxy furan (11.
5 mg, 0.0327 mmol), cyclooctanone (82.6 mg, 0.654 mmol), potassium carbonate (22.6 mg, 0.164 mmol), and methanol (0.3 mL) in a sealed tube at 120 ° C. Heated for days. The reaction mixture was concentrated under reduced pressure and the residue was subjected to silica gel thin layer chromatography (hexane / ethyl acetate).
Purify with 2: 1, 1% triethylamine) to give 5- (3-
Chloro-2-pyrrolyl) -2- (1-cyclooctenyl) -3-methoxyfuran (3.7 mg, 0.0121
mmol) was obtained in a yield of 37%.

【手続補正12】[Procedure amendment 12]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0124[Correction target item name] 0124

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0124】アルゴン気流中、室温で−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−
メトキシフラン(12.7mg,0.0361mmo
l)、2−アセチル−1−p−トルエンスルホニルピロ
ール(19.0mg,0.0722mmol)、及びオ
ルトギ酸トリメチル(0.050mL,0.46mmo
l)のメタノール(0.36mL)溶液にカンファース
ルホン酸(4.2mg,0.018mmol)を加え室
温で4時間かきまぜた。反応混合物をシリカゲル薄層ク
ロマトグラフィ(ヘキサン/酢酸エチル 2:1)で精
製して5−(3−クロロ−1−p−トルエンスルホニル
−2−ピロリル)−3−メトキシ−2−[1−(1−p
−トルエンスルホニル−2−ピロリル)エテニル]フラ
ン(7.1mg,0.0119mmol)を33%の収
率で得た。
[0124] In an argon gas stream at room temperature for 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 -
Methoxyfuran (12.7mg, 0.0361mmo
1), 2-acetyl-1-p-toluenesulfonylpyrrole (19.0 mg, 0.0722 mmol), and trimethyl orthoformate (0.050 mL, 0.46 mmo).
Camphorsulfonic acid (4.2 mg, 0.018 mmol) was added to a solution of 1) in methanol (0.36 mL), and the mixture was stirred at room temperature for 4 hours. The reaction mixture was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1) to give 5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxy-2- [1- (1 -P
-Toluenesulfonyl-2-pyrrolyl) ethenyl] furan (7.1 mg, 0.0119 mmol) was obtained in 33% yield.

【手続補正13】[Procedure amendment 13]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0128[Correction target item name] 0128

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0128】アルゴン気流中、室温で−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−
メトキシフラン(17.9mg,0.0509mmo
l)、2−アセチル−1−tert−ブトキシカルボニ
ルピロール(21.3mg,0.102mmol)、及
びオルトギ酸トリメチル(0.050mL,0.46m
mol)のメタノール(0.5mL)溶液にカンファー
スルホン酸(2.4mg,0.010mmol)を加え
室温で4時間かきまぜた。反応混合物を減圧下濃縮し、
残渣をシリカゲル薄層クロマトグラフィ(ヘキサン/酢
酸エチル 2:1)で精製して2−[1−(1−ter
t−ブトキシカルボニル−2−ピロリル)エテニル]−
5−(3−クロロ−1−p−トルエンスルホニル−2−
ピロリル)−3−メトキシフラン(12.1mg,0.
0223mmol)を44%の収率で得た。
[0128] In an argon gas stream at room temperature for 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 -
Methoxyfuran (17.9 mg, 0.0509 mmo
l), 2-acetyl-1-tert-butoxycarbonylpyrrole (21.3 mg, 0.102 mmol), and trimethyl orthoformate (0.050 mL, 0.46 m).
camphorsulfonic acid (2.4 mg, 0.010 mmol) was added to a methanol (0.5 mL) solution of (mol) and stirred at room temperature for 4 hours. The reaction mixture was concentrated under reduced pressure,
The residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1) to give 2- [1- (1-ter
t-butoxycarbonyl-2-pyrrolyl) ethenyl]-
5- (3-chloro-1-p-toluenesulfonyl-2-
Pyrrolyl) -3-methoxyfuran (12.1 mg, 0.
0223 mmol) was obtained in a yield of 44%.

【手続補正14】[Procedure Amendment 14]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0148[Correction target item name] 0148

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0148】アルゴン気流中、室温で−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−
メトキシフラン(12.3mg,0.0350mmo
l)、7−オキソ−1−p−トルエンスルホニル−4,
5,6,7−テトラヒドロインドール[参考文献:J.
Org.Chem.48,3214(1983)](2
0.2mg,0.0698mmol)、及びオルトギ酸
トリメチル(0.10mL,0.92mmol)のメタ
ノール(0.35mL)溶液にカンファースルホン酸
(1.6mg,0.0068mmol)を加え室温で7
時間かきまぜた。反応混合物を減圧下濃縮し、残渣をシ
リカゲル薄層クロマトグラフィ(ヘキサン/酢酸エチル
2:1,1%トリエチルアミン)で精製して5−(3
−クロロ−1−p−トルエンスルホニル−2−ピロリ
ル)−3−メトキシ−2−(1−p−トルエンスルホニ
ル−4,5−ジヒドロインドール−7−イル)フラン
(1.55mg,0.00249mmol)を7%の収
率で得た。
[0148] In an argon gas stream at room temperature for 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 -
Methoxyfuran (12.3mg, 0.0350mmo
l), 7-oxo-1-p-toluenesulfonyl-4,
5,6,7-Tetrahydroindole [Reference: J.
Org. Chem. 48, 3214 (1983)] (2
0.2 mg, 0.0698 mmol) and trimethyl orthoformate (0.10 mL, 0.92 mmol) in methanol (0.35 mL) were added with camphorsulfonic acid (1.6 mg, 0.0068 mmol) at room temperature.
Stir the time. The reaction mixture was concentrated under reduced pressure and the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine) to give 5- (3
-Chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-methoxy-2- (1-p-toluenesulfonyl-4,5-dihydroindol-7-yl) furan (1.55 mg, 0.00249 mmol) Was obtained in a yield of 7%.

【手続補正15】[Procedure Amendment 15]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0152[Correction target item name]

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0152】アルゴン気流中、室温で−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−
メトキシフラン(15.6mg,0.0443mmo
l)、1−tert−ブトキシカルボニル−7−オキソ
−4,5,6,7−テトラヒドロインドール[参考文
献:J.Org.Chem.48,3214(198
3)](20.9mg,0.0833mmol)、及び
オルトギ酸トリメチル(0.050mL,0.46mm
ol)のメタノール(0.35mL)溶液にカンファー
スルホン酸(2.1mg,0.0090mmol)を加
え室温で2時間かきまぜた。反応混合物を減圧下濃縮
し、残渣をシリカゲル薄層クロマトグラフィ(ヘキサン
/酢酸エチル 2:1,1%トリエチルアミン)で精製
して2−(1−tert−ブトキシカルボニル−4,5
−ジヒドロインドール−7−イル)−5−(3−クロロ
−1−p−トルエンスルホニル−2−ピロリル)−3−
メトキシフラン(6.4mg,0.011mmol)を
25%の収率で得た。
[0152] In an argon gas stream at room temperature for 2 - (3-chloro -1-p-toluenesulfonyl-2-pyrrolyl) - 4 -
Methoxyfuran (15.6mg, 0.0443mmo
l), 1-tert-butoxycarbonyl-7-oxo-4,5,6,7-tetrahydroindole [Reference: J. Org. Chem. 48, 3214 (198
3)] (20.9 mg, 0.0833 mmol), and trimethyl orthoformate (0.050 mL, 0.46 mm)
ol) in methanol (0.35 mL) was added camphorsulfonic acid (2.1 mg, 0.0090 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction mixture was concentrated under reduced pressure, the residue was purified by silica gel thin layer chromatography (hexane / ethyl acetate 2: 1, 1% triethylamine), and 2- (1-tert-butoxycarbonyl-4,5).
-Dihydroindol-7-yl) -5- (3-chloro-1-p-toluenesulfonyl-2-pyrrolyl) -3-
Methoxyfuran (6.4 mg, 0.011 mmol) was obtained in 25% yield.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式 【化1】 [式中、R1は水素原子またはSO23もしくはCO2
4で表される基(ただし、R3およびR4は各々、炭素数
1〜5の直鎖状もしくは分岐状アルキル基、置換もしく
は無置換のアラルキル基、または置換もしくは無置換の
アリ−ル基を表す)を表し、R2は炭素数1〜5の直鎖
状もしくは分岐状アルキル基、置換もしくは無置換のア
ラルキル基、または置換もしくは無置換のアリ−ル基を
表し、Xはハロゲン原子を表す。Aは下記一般式 【化2】 (式中、nは0〜3の整数を表す)、または下記一般式 【化3】 (式中、nは0〜3の整数を表す)、または下記一般式 【化4】 (式中、nは0〜3の整数を表す)、または下記一般式 【化5】 (式中、R5は水素原子またはSO26もしくはCO2
7で表される基(ただし、R6およびR7は各々、炭素数
1〜5の直鎖状もしくは分岐状アルキル基、置換もしく
は無置換のアラルキル基、または置換もしくは無置換の
アリ−ル基を表す))、あるいは下記一般式 【化6】 (式中、R5は前記と同様である)を表す]で表される
2−置換−3−アルコキシ−5−(ピロール−2−イ
ル)フラン誘導体。
1. The following general formula: [Wherein R 1 is a hydrogen atom or SO 2 R 3 or CO 2 R
A group represented by 4 (provided that R 3 and R 4 are each a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; R 2 represents a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and X represents a halogen atom. Represent A is the following general formula: (In the formula, n represents an integer of 0 to 3), or the following general formula: (In the formula, n represents an integer of 0 to 3), or the following general formula: (In the formula, n represents an integer of 0 to 3), or the following general formula: (In the formula, R 5 is a hydrogen atom or SO 2 R 6 or CO 2 R
A group represented by 7 (provided that R 6 and R 7 are each a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group; Represents)) or the following general formula: (In the formula, R 5 is the same as defined above), and is a 2-substituted-3-alkoxy-5- (pyrrol-2-yl) furan derivative.
【請求項2】 下記一般式 【化7】 [式中、R2は炭素数1〜5の直鎖状もしくは分岐状ア
ルキル基、置換もしくは無置換のアラルキル基、または
置換もしくは無置換のアリ−ル基を表し、Xはハロゲン
原子を表す。Aは下記 【化8】 で表される1−(2H−ピロール−2−イリデン)エチ
ル基、または下記 【化9】 で表される5,6−ジヒドロ−4H−インドール−7−
イル基]で表される2−置換−3−アルコキシ−5−
(ピロール−2−イル)フラン誘導体、またはその薬学
的に許容しうる塩。
2. The following general formula: [In the formula, R 2 represents a linear or branched alkyl group having 1 to 5 carbon atoms, a substituted or unsubstituted aralkyl group, or a substituted or unsubstituted aryl group, and X represents a halogen atom. A is the following 1- (2H-pyrrole-2-ylidene) ethyl group represented by: or the following: 5,6-dihydro-4H-indole-7- represented by
2-substituted-3-alkoxy-5-
(Pyrrol-2-yl) furan derivative, or a pharmaceutically acceptable salt thereof.
JP7199365A 1995-08-04 1995-08-04 2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative Pending JPH0948778A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7199365A JPH0948778A (en) 1995-08-04 1995-08-04 2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7199365A JPH0948778A (en) 1995-08-04 1995-08-04 2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative

Publications (1)

Publication Number Publication Date
JPH0948778A true JPH0948778A (en) 1997-02-18

Family

ID=16406551

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7199365A Pending JPH0948778A (en) 1995-08-04 1995-08-04 2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative

Country Status (1)

Country Link
JP (1) JPH0948778A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500204A (en) * 2003-05-26 2007-01-11 武田薬品工業株式会社 Sulfopyrrole
WO2007114338A1 (en) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited Acid secretion inhibitor
US8895588B2 (en) 2009-03-26 2014-11-25 Takeda Pharmaceutical Company Limited Pyrazole compound

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007500204A (en) * 2003-05-26 2007-01-11 武田薬品工業株式会社 Sulfopyrrole
JP4716996B2 (en) * 2003-05-26 2011-07-06 武田薬品工業株式会社 Sulfopyrrole
WO2007114338A1 (en) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited Acid secretion inhibitor
US7994205B2 (en) 2006-03-31 2011-08-09 Takeda Pharmaceutical Company Limited Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
JP5207964B2 (en) * 2006-03-31 2013-06-12 武田薬品工業株式会社 Acid secretion inhibitor
US8686010B2 (en) 2006-03-31 2014-04-01 Takeda Pharmaceutical Company Limited Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
US8895588B2 (en) 2009-03-26 2014-11-25 Takeda Pharmaceutical Company Limited Pyrazole compound

Similar Documents

Publication Publication Date Title
TW202002969A (en) Preparative process
Casaschi et al. Palladium catalysed tandem cyclisation–anion capture. Part 7: Synthesis of derivatives of α-amino esters, nitrogen heterocycles and β-aryl/heteroaryl ethylamines via in situ generated vinylstannanes
ES2204302B2 (en) PROCEDURE FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND.
JPH0948778A (en) 2-substituted-3-alkoxy-5-(pyrrol-2-yl)furan derivative
JPH0670049B2 (en) Method for N-alkylation of dihydrolysergic acid
Yamanaka et al. A convenient method for the synthesis of α-imidostyrenes from styrenes and imides via diphenylstyrylsulfonium salts
CN102442947B (en) Preparation method of Montelukast Sodium intermediate
US5712393A (en) Derivatives of 2-aminobenzenesulphonic acid and of 2-aminobenzenesulphonyl chloride, their preparation and their use as synthetic intermediates
WO2002070477A1 (en) 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor
US6710185B2 (en) Process for the preparation of cell proliferation inhibitors
JP7315805B1 (en) Method for producing intermediate for synthesis of monocyclic pyridine derivative
ES2283781T3 (en) PROCEDURE TO PRODUCE A COMPOSITE OF 1,2,3-TRIAZOL.
JP2002220371A (en) Method for producing n-vinyl carbazoles
JP2000007664A (en) Optically active piperazine compound, its intermediate and their production
JP2006176531A (en) Optical isomer of optically active benzimidazole derivative
JP2662162B2 (en) Method for producing 3-alkylpyrrole
KR20010043475A (en) Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds
JP4373031B2 (en) Process for producing 3-amino-4-substituted-5-pyrazolones
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
CN102442948B (en) Method for preparing montelukast sodium intermediate
JP2000007609A (en) Production of carboxylic acid derivative
EA002723B1 (en) Processes and intermediates useful to make antifolates
CN116655520A (en) Preparation method of 6, 6-dimethyl-3-aza [3.1.0] hexane-2-carboxylic acid derivative
JPH01226862A (en) Production of n,n-dialkylhydrazines
JP2000247970A (en) Production of 5-amino-8-methyl-7-pyprolidinylquinoline-3- carboxylic acid derivative and intermediate therefor